syndrome	score	normalized_score
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	2.00871399	100.0
NEUROBLASTOMA, SUSCEPTIBILITY TO	1.5	74.67464295402254
SACCHAROPINURIA	1.325	65.96260127605325
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	1.291667	64.30318136032895
DIBASIC AMINO ACIDURIA I	1.291666	64.30313157723366
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	1.12432737	55.972496612123464
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	1.0909091	54.308831691862714
DICARBOXYLICAMINO ACIDURIA	1.0136986	50.465054011995
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.00689655	50.126426908591405
DIMETHYLGLYCINE DEHYDROGENASE DEFICIENCY	1.0	49.783095302681694
ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	1.0	49.783095302681694
LARYNGOTRACHEAL ANGIOMA	1.0	49.783095302681694
LYSINURIC PROTEIN INTOLERANCE	0.791666	39.411583925892806
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.75942245	37.80640020334602
5-@OXOPROLINASE DEFICIENCY; OPLAHD	0.7	34.848166711877184
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.62597933	31.16318864289883
HYPERLYSINURIA WITH HYPERAMMONEMIA	0.625	31.114434564176058
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.625	31.114434564176058
HAWKINSINURIA	0.583333	29.04012233219922
HAWKINSINURIA	0.583333	29.04012233219922
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.54	26.882871463448115
PERIPARTUM CARDIOMYOPATHY	0.5298619	26.378165464959995
ARGININEMIA	0.50877193	25.3282414785193
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.50492611	25.13678465494234
HARTNUP DISEASE	0.50492611	25.13678465494234
HYPERTRYPTOPHANEMIA; HYPTRP	0.50444444	25.112805631427896
HARTNUP DISORDER	0.5	24.891547651340847
RODRIGUES BLINDNESS	0.5	24.891547651340847
TRYPTOPHANURIA WITH DWARFISM	0.5	24.891547651340847
THREONINEMIA	0.5	24.891547651340847
HSD10 DISEASE	0.5	24.891547651340847
GLUTATHIONE SYNTHETASE DEFICIENCY	0.5	24.891547651340847
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.5	24.891547651340847
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.5	24.891547651340847
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.5	24.891547651340847
LEBER CONGENITAL AMAUROSIS, TYPE I	0.5	24.891547651340847
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.5	24.891547651340847
KETOADIPICACIDURIA	0.5	24.891547651340847
UROCANIC ACIDURIA	0.5	24.891547651340847
MEVALONIC ACIDURIA; MEVA	0.5	24.891547651340847
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.45	22.402392886206762
IMINOGLYCINURIA	0.43376610000000004	21.594219095372562
HYPERPROLINEMIA, TYPE II	0.43376610000000004	21.594219095372562
HYPERPROLINEMIA, TYPE I	0.43376610000000004	21.594219095372562
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.4199345	20.905639234383987
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.4199345	20.905639234383987
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.38046478	18.940714402053825
POSTSYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.3596488	17.904430485895105
ADRENOCORTICAL CARCINOMA	0.34595141999999995	17.22253251195806
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.3368791	16.770884340781635
HEREDITARY MYOPATHY WITH EARLY RESPIRATORY FAILURE	0.333333	16.594348506528796
PENTOSURIA	0.333333	16.594348506528796
DIAMINOPENTANURIA	0.325	16.17950597337155
FANCONI RENOTUBULAR SYNDROME 1; FRTS1	0.2636986	13.127732534983739
HOMOCARNOSINOSIS	0.25	12.445773825670424
CARNOSINEMIA	0.25	12.445773825670424
CYSTATHIONINURIA	0.25	12.445773825670424
MUSCULAR DYSTROPHY, CARDIAC TYPE	0.25	12.445773825670424
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.25	12.445773825670424
TYROSINE TRANSAMINASE DEFICIENCY	0.25	12.445773825670424
CARNOSINASE DEFICIENCY	0.25	12.445773825670424
CYSTATHIONINURIA	0.25	12.445773825670424
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.2285714	11.37899178966738
CONGENITAL MYASTHENIC SYNDROME	0.2285714	11.37899178966738
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.216667	10.786353909946135
HISTIDINEMIA	0.20877193000000002	10.393312887714792
HISTIDINEMIA	0.20877193000000002	10.393312887714792
CRI-DU-CHAT SYNDROME	0.20492611000000002	10.201856064137834
HYPOTONIA-CYSTINURIA SYNDROME	0.2035461	10.133154894789179
CONGENITAL TOTAL PULMONARY VENOUS RETURN ANOMALY	0.20199338	10.055855687050798
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.2	9.95661906053634
2P21 MICRODELETION SYNDROME	0.2	9.95661906053634
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	0.2	9.95661906053634
HYPOTONIA-CYSTINURIA SYNDROME	0.2	9.95661906053634
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.2	9.95661906053634
HISTIDINURIA-RENAL TUBULAR DEFECT SYNDROME	0.2	9.95661906053634
TRANSALDOLASE DEFICIENCY	0.2	9.95661906053634
HYPERPROLINEMIA TYPE 1	0.2	9.95661906053634
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.2	9.95661906053634
ESOPHAGEAL ATRESIA	0.2	9.95661906053634
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.2	9.95661906053634
FAMILIAL AORTIC DISSECTION	0.1929828	9.607281124178362
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.1929828	9.607281124178362
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.1929828	9.607281124178362
PARAGANGLIOMAS 1	0.17435931000000002	8.680146146639823
PARAGANGLIOMAS 4	0.17435931000000002	8.680146146639823
PARAGANGLIOMAS 3	0.17435931000000002	8.680146146639823
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.17187533000000002	8.556485933569867
TRIGEMINAL NEURALGIA	0.17111144	8.5184571248991
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.1702131	8.47373497906489
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.1702131	8.47373497906489
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.1702131	8.47373497906489
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.1699345	8.459865408713561
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.1699345	8.459865408713561
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.1699345	8.459865408713561
ETHYLMALONIC ENCEPHALOPATHY	0.166667	8.297199144812051
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.166667	8.297199144812051
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.166667	8.297199144812051
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.166667	8.297199144812051
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.1575758	7.844611068796309
BRUCK SYNDROME 2	0.14285699999999998	7.111863645655197
HYPER-BETA-ALANINEMIA	0.14285699999999998	7.111863645655197
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.14285699999999998	7.111863645655197
HYPERTAURINURIC CARDIOMYOPATHY	0.14285699999999998	7.111863645655197
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.14285699999999998	7.111863645655197
PAGET DISEASE OF BONE 2, EARLY-ONSET; PDB2	0.14285699999999998	7.111863645655197
CAMPTODACTYLY 1; CAMPD1	0.14285699999999998	7.111863645655197
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.14285699999999998	7.111863645655197
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.14285699999999998	7.111863645655197
CAMPTODACTYLY-TAURINURIA SYNDROME	0.14285699999999998	7.111863645655197
FAMILIAL EXPANSILE OSTEOLYSIS	0.14285699999999998	7.111863645655197
BARTH SYNDROME; BTHS	0.1341017	6.675997711351629
HYDROXYLYSINURIA	0.125	6.222886912835212
GLUTARIC ACIDEMIA I; GA1	0.125	6.222886912835212
LYSINE MALABSORPTION SYNDROME	0.125	6.222886912835212
HYPEROXALURIA, PRIMARY, TYPE II; HP2	0.12480959999999999	6.213408211489581
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.1212121	6.034313526138184
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.1212121	6.034313526138184
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.11190470000000001	5.570962344918005
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.11111099999999999	5.531449502176265
PRIMARY HYPEROXALURIA	0.11111099999999999	5.531449502176265
HYPEROXALURIA, PRIMARY, TYPE I; HP1	0.11111099999999999	5.531449502176265
NEPHROLITHIASIS, CALCIUM OXALATE	0.11111099999999999	5.531449502176265
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.11111099999999999	5.531449502176265
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.11111099999999999	5.531449502176265
PRIMARY HYPEROXALURIA TYPE 2	0.11111099999999999	5.531449502176265
PRIMARY HYPEROXALURIA TYPE 3	0.11111099999999999	5.531449502176265
PRIMARY HYPEROXALURIA TYPE 1	0.11111099999999999	5.531449502176265
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.104798	5.217168821530437
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.0970319	4.830548325100279
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.0941919	4.6891643344406635
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0909091	4.52573638918102
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.0909091	4.52573638918102
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.0909091	4.52573638918102
RIBOFLAVIN DEFICIENCY	0.0909091	4.52573638918102
GLYCINE ENCEPHALOPATHY; GCE	0.0909091	4.52573638918102
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.0909091	4.52573638918102
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.0909091	4.52573638918102
INDOLYLACROYL GLYCINURIA WITH MENTAL RETARDATION	0.0909091	4.52573638918102
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.0909091	4.52573638918102
GLYCINURIA WITH OR WITHOUT OXALATE UROLITHIASIS	0.0909091	4.52573638918102
GLUCOGLYCINURIA	0.0909091	4.52573638918102
PROPIONIC ACIDEMIA	0.0909091	4.52573638918102
CYSTINOSIS, NEPHROPATHIC; CTNS	0.08854163000000001	4.407876404544782
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.08576392999999999	4.269593900722521
MACULAR DYSTROPHY, RETINAL, 1, NORTH CAROLINA TYPE	0.08333330000000001	4.148589615786965
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.08333330000000001	4.148589615786965
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.08333330000000001	4.148589615786965
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.08333330000000001	4.148589615786965
TYROSINEMIA TYPE 1	0.08333330000000001	4.148589615786965
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.08333330000000001	4.148589615786965
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.08129403	4.047068443029065
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.0803653	4.000833388928606
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV; MEN4	0.08	3.982647624214536
SENGERS SYNDROME	0.07264332999999999	3.6164098204941557
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.0725221	3.6103746158506125
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.07213117999999999	3.5909134082348872
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.07213117999999999	3.5909134082348872
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.06759543	3.3651097337157494
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.0666667	3.318874679615289
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.0666667	3.318874679615289
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.0666667	3.318874679615289
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.0666667	3.318874679615289
AMISH LETHAL MICROCEPHALY	0.0666667	3.318874679615289
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.0666667	3.318874679615289
PROPIONIC ACIDEMIA	0.0666667	3.318874679615289
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.0666667	3.318874679615289
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.0666667	3.318874679615289
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.06453996999999999	3.212999477342217
METHYLMALONIC ACIDURIA, CBLB TYPE	0.06428798	3.2004546351568943
8Q24.3 MICRODELETION SYNDROME	0.06428798	3.2004546351568943
METHYLMALONIC ACIDURIA, CBLA TYPE	0.06428798	3.2004546351568943
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.06428798	3.2004546351568943
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.06233494	3.103226258706945
MCLEOD SYNDROME; MCLDS	0.061010879999999997	3.0373104535404765
RHEUMATOID ARTHRITIS	0.0607197	3.022814611850242
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.05936778	2.9555118496486403
SECKEL SYNDROME 10; SCKL10	0.0588235	2.928415906537297
BASAL CELL NEVUS SYNDROME	0.0588235	2.928415906537297
BARTSOCAS-PAPAS SYNDROME; BPS	0.0588235	2.928415906537297
LUMBAR SYNDROME	0.0588235	2.928415906537297
BIRT-HOGG-DUBÉ SYNDROME	0.0588235	2.928415906537297
CLEFT, MEDIAN, OF UPPER LIP WITH POLYPS OF FACIAL SKIN AND NASAL MUCOSA	0.0588235	2.928415906537297
GAPO SYNDROME	0.0588235	2.928415906537297
COWDEN SYNDROME 6; CWS6	0.0588235	2.928415906537297
TRANSCOBALAMIN DEFICIENCY	0.0588235	2.928415906537297
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.0588235	2.928415906537297
AICARDI SYNDROME; AIC	0.0588235	2.928415906537297
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.0588235	2.928415906537297
PAI SYNDROME	0.0588235	2.928415906537297
COWDEN SYNDROME 5; CWS5	0.0588235	2.928415906537297
CUSHING DISEASE	0.05812497999999999	2.893641418806467
178610 PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL	0.05736720000000001	2.8559167848480014
HYDROXYKYNURENINURIA	0.0571769	2.8464430618119008
MYOPATHY WITH EXERCISE INTOLERANCE, SWEDISH TYPE	0.05629678	2.8026279639741047
TUBEROUS SCLEROSIS COMPLEX	0.05483503	2.7298575244154097
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.05312135	2.64454522965711
ACTH-DEPENDENT CUSHING SYNDROME	0.052916649999999996	2.634354630048651
FAMILIAL COLORECTAL CANCER TYPE X	0.052916649999999996	2.634354630048651
LYNCH SYNDROME	0.052916649999999996	2.634354630048651
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.05	2.489154765134085
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.05	2.489154765134085
DILATED CARDIOMYOPATHY WITH ATAXIA	0.05	2.489154765134085
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.05	2.489154765134085
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.05	2.489154765134085
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.05	2.489154765134085
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.05	2.489154765134085
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.05	2.489154765134085
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.05	2.489154765134085
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.05	2.489154765134085
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.05	2.489154765134085
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.05	2.489154765134085
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.05	2.489154765134085
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.05	2.489154765134085
PHOSPHOGLYCERATE MUTASE, MUSCLE, DEFICIENCY OF	0.049400229999999996	2.459296358064395
EISENMENGER SYNDROME	0.04921528	2.4500889745881644
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.04914484	2.4465822533550434
PELIZAEUS-MERZBACHER DISEASE	0.048771930000000005	2.4280176392857205
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.04863634	2.4212675493936295
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.047266180000000005	2.353056743533708
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.04702440000000001	2.3410201867514253
NEUROLEPTIC MALIGNANT SYNDROME	0.04646751999999999	2.313296976639267
KOOLEN-DE VRIES SYNDROME; KDVS	0.04492611	2.236560815708761
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.0447004	2.225324273267993
GLUCAGONOMA	0.04444444	2.2125817921943183
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.04444444	2.2125817921943183
PURE MITOCHONDRIAL MYOPATHY	0.0441919	2.200009569306579
GLYCOGEN STORAGE DISEASE XI; GSD11	0.0441919	2.200009569306579
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.0441919	2.200009569306579
ALKAPTONURIA	0.04378788	2.1798962031423894
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.043546100000000004	2.1678596463601076
BLACKFAN-DIAMOND ANEMIA	0.043546100000000004	2.1678596463601076
PITUITARY APOPLEXY	0.043546100000000004	2.1678596463601076
NEUROFIBROMATOSIS TYPE 1	0.043478300000000004	2.1644843524985857
SLC35A2-CDG	0.043478300000000004	2.1644843524985857
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.043478300000000004	2.1644843524985857
FASCIAL DYSTROPHY, CONGENITAL	0.043478300000000004	2.1644843524985857
HEMOSIDEROSIS, PULMONARY, WITH DEFICIENCY OF GAMMA-A GLOBULIN	0.043478300000000004	2.1644843524985857
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.043478300000000004	2.1644843524985857
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.043478300000000004	2.1644843524985857
JUVENILE XANTHOGRANULOMA	0.043478300000000004	2.1644843524985857
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.043478300000000004	2.1644843524985857
WHITE FORELOCK WITH MALFORMATIONS	0.043478300000000004	2.1644843524985857
HYPOPLASMINOGENEMIA	0.043478300000000004	2.1644843524985857
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.043478300000000004	2.1644843524985857
PSEUDOTRISOMY 13 SYNDROME	0.043478300000000004	2.1644843524985857
LICHTENSTEIN SYNDROME	0.043478300000000004	2.1644843524985857
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.043478300000000004	2.1644843524985857
NEONATAL LUPUS ERYTHEMATOSUS	0.043478300000000004	2.1644843524985857
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.043478300000000004	2.1644843524985857
GITELMAN SYNDROME	0.04345979	2.163562867404533
SCIMITAR SYNDROME	0.04250148	2.1158552293450197
300270 ADRENOMYODYSTROPHY	0.04224533	2.103103289483238
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.0402047	2.0015144117157266
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.0400144	1.9920406886796262
VIPOMA	0.04	1.991323812107268
MAFFUCCI SYNDROME	0.04	1.991323812107268
MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	0.04	1.991323812107268
3Q13 MICRODELETION SYNDROME	0.04	1.991323812107268
SOMATOSTATINOMA	0.04	1.991323812107268
GRFOMA	0.04	1.991323812107268
DISTAL MONOSOMY 12Q	0.04	1.991323812107268
PPOMA	0.04	1.991323812107268
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.04	1.991323812107268
NON-DISTAL TRISOMY 10Q	0.04	1.991323812107268
PITUITARY ADENOMA, GROWTH HORMONE-SECRETING, 1	0.04	1.991323812107268
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.04	1.991323812107268
HYDROCEPHALY-LOW INSERTION UMBILICUS SYNDROME	0.04	1.991323812107268
104600 AMENORRHEA-GALACTORRHEA SYNDROME	0.04	1.991323812107268
PITUITARY ADENOMA 5, MULTIPLE TYPES; PITA5	0.04	1.991323812107268
SMITH-MAGENIS SYNDROME; SMS	0.04	1.991323812107268
SPLIT HAND/FOOT MALFORMATION 1 (SHFM1)	0.04	1.991323812107268
KAPUR-TORIELLO SYNDROME	0.04	1.991323812107268
CEREBELLAR VERMIS APLASIA WITH ASSOCIATED FEATURES SUGGESTING SMITH-LEMLI-OPITZSYNDROME AND MECKEL SYNDROME	0.04	1.991323812107268
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASEDEFICIENCY	0.04	1.991323812107268
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.04	1.991323812107268
TURCOT SYNDROME WITH POLYPOSIS	0.04	1.991323812107268
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.04	1.991323812107268
PITUITARY ADENOMA 2, GROWTH HORMONE-SECRETING; PITA2	0.04	1.991323812107268
CHROMOSOME XQ26.3 DUPLICATION SYNDROME	0.04	1.991323812107268
MECKEL SYNDROME, TYPE 5	0.04	1.991323812107268
COCAINE EMBRYOFETOPATHY	0.04	1.991323812107268
CARNEY COMPLEX, TYPE 1; CNC1	0.04	1.991323812107268
TRISOMY 12P	0.04	1.991323812107268
GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM	0.04	1.991323812107268
OCULOCEREBRORENAL SYNDROME OF LOWE	0.039198149999999994	1.9514052371388122
THYROTOXIC PERIODIC PARALYSIS	0.03799531	1.8915241387849346
LEUKEMIA, ACUTE MYELOCYTIC, WITH POLYPOSIS COLI AND COLON CANCER	0.037037	1.8438165007254217
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.037037	1.8438165007254217
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.037037	1.8438165007254217
NATHALIE SYNDROME	0.037037	1.8438165007254217
HYPERLYSINEMIA, TYPE I	0.037037	1.8438165007254217
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.037037	1.8438165007254217
LABIA MINORA, INCOMPLETE ADHESION OF	0.037037	1.8438165007254217
FAMILIAL SUPERNUMERARY NIPPLES	0.037037	1.8438165007254217
GALACTORRHEA	0.037037	1.8438165007254217
GENITOURINARY TRACT ANOMALIES	0.037037	1.8438165007254217
PEYRONIE DISEASE	0.037037	1.8438165007254217
ADENOMYOSIS	0.037037	1.8438165007254217
DK PHOCOMELIA SYNDROME	0.037037	1.8438165007254217
207620 APHALANGY WITH HEMIVERTEBRAE	0.037037	1.8438165007254217
VISCERAL STEATOSIS, CONGENITAL	0.037037	1.8438165007254217
FRYNS MICROPHTHALMIA SYNDROME	0.037037	1.8438165007254217
TESTICULAR TORSION	0.037037	1.8438165007254217
SPLENOGONADAL FUSION WITH LIMB DEFECTS AND MICROGNATHIA	0.037037	1.8438165007254217
138790 GOITER, MULTINODULAR, CYSTIC RENAL DISEASE, AND DIGITAL ANOMALIES;;MULTINODULAR GOITER/CYSTIC RENAL DISEASE/DIGITAL ANOMALIES;;MNG/CRD/DA	0.037037	1.8438165007254217
OVARIAN HYPERSTIMULATION SYNDROME	0.037037	1.8438165007254217
HYDATIDIFORM MOLE, RECURRENT, 1; HYDM1	0.037037	1.8438165007254217
URINARY BLADDER, ATONY OF	0.037037	1.8438165007254217
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.03698861	1.841407496743725
ACHONDROPLASIA	0.03626371	1.8053197309588112
LEPTOSPIROSIS	0.03576748	1.7806158655767612
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.035511329999999994	1.767863925714979
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.035511329999999994	1.767863925714979
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	0.034306340000000005	1.7078757937062015
RAYNAUD-CLAES SYNDROME; MRXSRC	0.03427148	1.7061403550039496
AURICULOCONDYLAR SYNDROME	0.03403588	1.6944114577506375
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.03403588	1.6944114577506375
GITELMAN SYNDROME	0.03384909999999999	1.6851129712100024
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.03349751	1.667609732732533
WILLIAMS SYNDROME	0.03070788	1.528733316583313
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 4	0.030302999999999997	1.5085771369571632
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.030302999999999997	1.5085771369571632
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.030302999999999997	1.5085771369571632
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, MYOPATHIC, STRESS-INDUCED	0.030302999999999997	1.5085771369571632
MEDIUM CHAIN 3-KETOACYL-COA THIOLASE DEFICIENCY	0.030302999999999997	1.5085771369571632
THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 1; TTPP1	0.030302999999999997	1.5085771369571632
DISTAL ANOCTAMINOPATHY	0.030302999999999997	1.5085771369571632
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.030302999999999997	1.5085771369571632
MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY	0.030302999999999997	1.5085771369571632
GLYCOGEN STORAGE DISEASE DUE TO LACTATE DEHYDROGENASE DEFICIENCY	0.030302999999999997	1.5085771369571632
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.030302999999999997	1.5085771369571632
ACUTE PROMYELOCYTIC LEUKEMIA	0.0298619	1.4866178136191506
REFRACTORY ANEMIA WITH EXCESS BLASTS	0.0298619	1.4866178136191506
265400 PULMONARY HYPERTENSION, PRIMARY, AUTOSOMAL RECESSIVE	0.0298619	1.4866178136191506
MIXED-TYPE AUTOIMMUNE HEMOLYTIC ANEMIA	0.0298619	1.4866178136191506
PRIMARY FAMILIAL POLYCYTHEMIA	0.0298619	1.4866178136191506
DRUG-INDUCED AUTOIMMUNE HEMOLYTIC ANEMIA	0.0298619	1.4866178136191506
POLYMYOSITIS	0.0298619	1.4866178136191506
AUTOIMMUNE HEMOLYTIC ANEMIA, WARM TYPE	0.0298619	1.4866178136191506
ACUTE MONOBLASTIC LEUKEMIA	0.0298619	1.4866178136191506
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.02904565	1.4459823620783365
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.0285714	1.4223727291310397
HURLER-SCHEIE SYNDROME	0.0285714	1.4223727291310397
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.0285714	1.4223727291310397
MARSHALL-SMITH SYNDROME; MRSHSS	0.0285714	1.4223727291310397
SCHEIE SYNDROME	0.0285714	1.4223727291310397
XIA-GIBBS SYNDROME	0.0285714	1.4223727291310397
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.0285714	1.4223727291310397
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.0285714	1.4223727291310397
MUCOPOLYSACCHARIDOSIS, TYPE II	0.0285714	1.4223727291310397
13Q12.3 MICRODELETION SYNDROME	0.0285714	1.4223727291310397
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.0285714	1.4223727291310397
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.0285714	1.4223727291310397
CHERUBISM	0.0285714	1.4223727291310397
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.0285714	1.4223727291310397
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.0285714	1.4223727291310397
TURNPENNY-FRY SYNDROME; TPFS	0.0285714	1.4223727291310397
MARFANOID HABITUS WITH SITUS INVERSUS	0.0285714	1.4223727291310397
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.0285714	1.4223727291310397
COSTELLO SYNDROME; CSTLO	0.0285714	1.4223727291310397
APNEA, OBSTRUCTIVE SLEEP	0.0285714	1.4223727291310397
DYSOSTEOSCLEROSIS	0.0285714	1.4223727291310397
PRADER-WILLI SYNDROME	0.0285714	1.4223727291310397
HALLERMANN-STREIFF SYNDROME; HSS	0.0285714	1.4223727291310397
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.0285714	1.4223727291310397
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.02846778	1.4172142047957759
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.02750551	1.3693094256788643
ADNP SYNDROME	0.02651959	1.3202272763580443
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 8; CMH8	0.0263158	1.310081979366311
GLYCOGEN STORAGE DISEASE WITH SEVERE CARDIOMYOPATHY DUE TO GLYCOGENIN DEFICIENCY	0.0263158	1.310081979366311
PULMONARY FIBROSIS, IDIOPATHIC; IPF	0.0263158	1.310081979366311
DISTAL NEBULIN MYOPATHY	0.0263158	1.310081979366311
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.0263158	1.310081979366311
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.0263158	1.310081979366311
IDIOPATHIC PULMONARY FIBROSIS	0.0263158	1.310081979366311
FAMILIAL ATRIAL MYXOMA	0.0263158	1.310081979366311
HEREDITARY METHEMOGLOBINEMIA	0.0263158	1.310081979366311
CONGENITAL AORTIC VALVE STENOSIS	0.0263158	1.310081979366311
PARTIAL ATRIOVENTRICULAR CANAL	0.0263158	1.310081979366311
LARYNGEAL NEUROENDOCRINE TUMOR	0.0263158	1.310081979366311
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.02599378	1.2940508270169415
PHENYLKETONURIA	0.02549955	1.269446527825497
DYSTONIA 11, MYOCLONIC	0.02549955	1.269446527825497
OBSESSIVE-COMPULSIVE DISORDER 1	0.02549955	1.269446527825497
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.02549955	1.269446527825497
EARLY-ONSET SCHIZOPHRENIA	0.02549955	1.269446527825497
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.02549955	1.269446527825497
MYOCLONUS-DYSTONIA SYNDROME	0.02549955	1.269446527825497
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.02549955	1.269446527825497
ERYTHERMALGIA, PRIMARY	0.02493371	1.2412772611794276
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.02484299	1.2367609387735683
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.02456171	1.22275794972683
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.02433155	1.2112998725119648
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.024137950000000002	1.2016618652613658
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.02354167	1.1719772011942826
CONGENITAL TRACHEAL STENOSIS	0.02270588	1.1303689879712542
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.02264333	1.1272550553600715
CYSTINOSIS	0.02245303	1.1177813323239711
MYOPATHY, CONGENITAL	0.02244973	1.1176170481094725
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.02187944	1.089226246689306
BRAIN-LUNG-THYROID SYNDROME	0.021593479999999998	1.074990272756551
AUTOSOMAL RECESSIVE AXONAL NEUROPATHY WITH NEUROMYOTONIA	0.02158121	1.0743794341771873
PEELING SKIN SYNDROME	0.02139091	1.064905711141087
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.02105511	1.0481885477384463
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.02105511	1.0481885477384463
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.02105511	1.0481885477384463
11Q22.2Q22.3 MICRODELETION SYNDROME	0.02105511	1.0481885477384463
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.02105511	1.0481885477384463
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.02105511	1.0481885477384463
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.02105511	1.0481885477384463
22Q11.2 MICRODUPLICATION SYNDROME	0.02105511	1.0481885477384463
CORNELIA DE LANGE SYNDROME	0.02105511	1.0481885477384463
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.02105511	1.0481885477384463
GRANULOMAS, CONGENITAL CEREBRAL	0.02102928	1.0469026503867782
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.02102928	1.0469026503867782
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.02102928	1.0469026503867782
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.02102928	1.0469026503867782
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.02102928	1.0469026503867782
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0207875	1.0348660936044958
KAPOSIFORM LYMPHANGIOMATOSIS	0.02078545	1.0347640382591252
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.02078545	1.0347640382591252
ACROMEGALY	0.02060896	1.025977819769155
SOMATOMAMMOTROPINOMA	0.02060896	1.025977819769155
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.02059515	1.0252903152230248
INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	0.02059515	1.0252903152230248
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.02057344	1.0242095242240035
ALSTRÖM SYNDROME	0.02057344	1.0242095242240035
MANGANESE POISONING	0.02057344	1.0242095242240035
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.02057344	1.0242095242240035
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.02057344	1.0242095242240035
AMYOTROPHIC LATERAL SCLEROSIS	0.019813200000000003	0.9863624238510931
CUTANEOUS MASTOCYTOSIS	0.0198132	0.986362423851093
FABRY DISEASE	0.0198132	0.986362423851093
MYOPATHY AND DIABETES MELLITUS	0.01935338	0.9634711609690138
BRONCHOPULMONARY DYSPLASIA	0.01935338	0.9634711609690138
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.01909723	0.9507192211072318
NEMALINE MYOPATHY 6	0.01909723	0.9507192211072318
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.01890693	0.9412454980711314
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.01838113	0.9150695465609815
PLAGUE	0.01838113	0.9150695465609815
ERDHEIM-CHESTER DISEASE	0.018134960000000002	0.9028144419903205
HODGKIN LYMPHOMA	0.018134960000000002	0.9028144419903205
THYMIC CARCINOMA	0.018134960000000002	0.9028144419903205
CUSHING SYNDROME	0.01812498	0.9023176066991996
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.01812498	0.9023176066991996
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.01767678	0.8800048233845377
BECKER MUSCULAR DYSTROPHY	0.017435	0.8679682666022552
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.017435	0.8679682666022552
XERODERMA PIGMENTOSUM	0.017244699999999998	0.8584945435661548
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.8583302593516562
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.8583302593516562
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.8583302593516562
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.8583302593516562
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.8583302593516562
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.8583302593516562
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.8583302593516562
MOSAIC TRISOMY 15	0.0172414	0.8583302593516562
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.8583302593516562
CARDIAC ARRHYTHMIA	0.0172414	0.8583302593516562
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.8583302593516562
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.8583302593516562
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.8583302593516562
PALMOMENTAL REFLEX	0.0172414	0.8583302593516562
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.8583302593516562
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.8583302593516562
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.8583302593516562
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.8583302593516562
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.8583302593516562
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.8583302593516562
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.8583302593516562
CERVICAL RIB	0.0172414	0.8583302593516562
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.8583302593516562
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.8583302593516562
MOTION SICKNESS	0.0172414	0.8583302593516562
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.8583302593516562
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.8583302593516562
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.8583302593516562
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.8583302593516562
THUMBS, CONGENITAL CLASPED	0.0172414	0.8583302593516562
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.8583302593516562
SICKLE CELL ANEMIA	0.0172414	0.8583302593516562
TRANSSEXUALITY	0.0172414	0.8583302593516562
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.8583302593516562
JUMPING FRENCHMAN OF MAINE	0.0172414	0.8583302593516562
DIASTEMATOMYELIA	0.0172414	0.8583302593516562
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.8583302593516562
ALCOHOL DEPENDENCE	0.0172414	0.8583302593516562
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.8583302593516562
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.8583302593516562
269800 SENILE PLAQUE FORMATION	0.0172414	0.8583302593516562
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.8583302593516562
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.8583302593516562
ACUTE INTERMITTENT PORPHYRIA	0.01706286	0.8494419855163153
STIFF-PERSON SYNDROME; SPS	0.01706286	0.8494419855163153
FAMILIAL DYSAUTONOMIA	0.01646424	0.819640829006224
DIENCEPHALIC SYNDROME	0.01646424	0.819640829006224
BETA-THALASSEMIA MAJOR	0.0162671	0.8098265895982534
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.0162671	0.8098265895982534
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.0162671	0.8098265895982534
AUTOIMMUNE HYPOPARATHYROIDISM	0.0162671	0.8098265895982534
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.0162671	0.8098265895982534
INSULINOMA	0.01616452	0.8047198396821044
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.01614891	0.8039427255644294
15Q11Q13 MICRODUPLICATION SYNDROME	0.016128999999999998	0.8029515441369529
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.016128999999999998	0.8029515441369529
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.016128999999999998	0.8029515441369529
COASY PROTEIN-ASSOCIATED NEURODEGENERATION	0.016128999999999998	0.8029515441369529
17Q21.31 MICRODUPLICATION SYNDROME	0.016128999999999998	0.8029515441369529
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.016128999999999998	0.8029515441369529
KLEEFSTRA SYNDROME	0.016128999999999998	0.8029515441369529
TRANSKETOLASE DEFICIENCY	0.016128999999999998	0.8029515441369529
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.016128999999999998	0.8029515441369529
16P13.11 MICRODELETION SYNDROME	0.016128999999999998	0.8029515441369529
TRICHOTILLOMANIA; TTM	0.016128999999999998	0.8029515441369529
COFFIN-SIRIS SYNDROME 1; CSS1	0.016128999999999998	0.8029515441369529
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.016128999999999998	0.8029515441369529
FG SYNDROME TYPE 1	0.016128999999999998	0.8029515441369529
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.016128999999999998	0.8029515441369529
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.016128999999999998	0.8029515441369529
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.016128999999999998	0.8029515441369529
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.016128999999999998	0.8029515441369529
HELSMOORTEL-VAN DER AA SYNDROME	0.016128999999999998	0.8029515441369529
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.016128999999999998	0.8029515441369529
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.016128999999999998	0.8029515441369529
FRAXE INTELLECTUAL DISABILITY	0.016128999999999998	0.8029515441369529
COFFIN-SIRIS SYNDROME 7; CSS7	0.016128999999999998	0.8029515441369529
2Q37 MICRODELETION SYNDROME	0.016128999999999998	0.8029515441369529
CHARGE SYNDROME	0.016128999999999998	0.8029515441369529
SYDENHAM CHOREA	0.016128999999999998	0.8029515441369529
GIANT CELL ARTERITIS	0.01568285	0.7807408161676617
POSTORGASMIC ILLNESS SYNDROME	0.01568285	0.7807408161676617
BABESIOSIS	0.01568285	0.7807408161676617
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Y	0.015668480000000002	0.7800254330881622
17Q23.1Q23.2 MICRODELETION SYNDROME	0.015668480000000002	0.7800254330881622
AREGENERATIVE ANEMIA	0.014887090000000002	0.7411254202495997
SCRUB TYPHUS	0.01458886	0.7262786077374809
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.01458886	0.7262786077374809
USHER SYNDROME	0.014578879999999999	0.72578177244636
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.014236410000000001	0.7087325557980507
CRYPTOCOCCOSIS	0.014236410000000001	0.7087325557980507
ACQUIRED METHEMOGLOBINEMIA	0.013936690000000002	0.693811566473931
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.01393669	0.6938115664739309
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.013888900000000001	0.6914324323494158
EXERCISE INTOLERANCE, RIBOFLAVIN-RESPONSIVE	0.013888900000000001	0.6914324323494158
GLYCOGEN STORAGE DISEASE XIII; GSD13	0.013888900000000001	0.6914324323494158
HISTIOCYTOID CARDIOMYOPATHY	0.013888900000000001	0.6914324323494158
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.013888900000000001	0.6914324323494158
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.013888900000000001	0.6914324323494158
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.013888900000000001	0.6914324323494158
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29; MC1DN29	0.013888900000000001	0.6914324323494158
MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD	0.013888900000000001	0.6914324323494158
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.013888900000000001	0.6914324323494158
MUSCLE GLYCOGENOSIS, X-LINKED	0.013888900000000001	0.6914324323494158
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.013888900000000001	0.6914324323494158
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.013888900000000001	0.6914324323494158
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 25; LGMDR25	0.013888900000000001	0.6914324323494158
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.013888900000000001	0.6914324323494158
AUTOSOMAL DOMINANT MITOCHONDRIAL MYOPATHY WITH EXERCISE INTOLERANCE	0.013888900000000001	0.6914324323494158
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2; PEOA2	0.013888900000000001	0.6914324323494158
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.013888900000000001	0.6914324323494158
MYOPATHIC EHLERS-DANLOS SYNDROME	0.013888900000000001	0.6914324323494158
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.013888900000000001	0.6914324323494158
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.013888900000000001	0.6914324323494158
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.013888900000000001	0.6914324323494158
GLYCOGEN STORAGE DISEASE VII	0.013888900000000001	0.6914324323494158
CYCLIC VOMITING SYNDROME	0.013888900000000001	0.6914324323494158
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.013888900000000001	0.6914324323494158
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.013888900000000001	0.6914324323494158
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.013888900000000001	0.6914324323494158
FORMIMINOTRANSFERASE DEFICIENCY	0.013698599999999998	0.6819587093133154
GALACTOSEMIA	0.013698599999999998	0.6819587093133154
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.013698599999999998	0.6819587093133154
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.013698599999999998	0.6819587093133154
SIALIDOSIS TYPE 1	0.013698599999999998	0.6819587093133154
FUMARASE DEFICIENCY; FMRD	0.013698599999999998	0.6819587093133154
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.013698599999999998	0.6819587093133154
NEPHROPATHIC INFANTILE CYSTINOSIS	0.013698599999999998	0.6819587093133154
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.013698599999999998	0.6819587093133154
ICHTHYOSIS-INTELLECTUAL DISABILITY-DWARFISM-RENAL IMPAIRMENT SYNDROME	0.013698599999999998	0.6819587093133154
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.013698599999999998	0.6819587093133154
ALKAPTONURIA	0.013698599999999998	0.6819587093133154
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.013698599999999998	0.6819587093133154
GYRATE ATROPHY OF CHOROID AND RETINA	0.013698599999999998	0.6819587093133154
ROWLEY-ROSENBERG SYNDROME	0.013698599999999998	0.6819587093133154
PROTEINURIA, LOW MOLECULAR WEIGHT, WITH HYPERCALCIURIA AND NEPHROCALCINOSIS	0.013698599999999998	0.6819587093133154
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.013698599999999998	0.6819587093133154
TIGLIC ACIDEMIA	0.013698599999999998	0.6819587093133154
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.013698599999999998	0.6819587093133154
ORNITHINE TRANSCARBAMYLASE DEFICIENCY	0.013698599999999998	0.6819587093133154
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.013698599999999998	0.6819587093133154
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.013698599999999998	0.6819587093133154
LYSINURIC PROTEIN INTOLERANCE; LPI	0.013698599999999998	0.6819587093133154
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.013698599999999998	0.6819587093133154
STIMMLER SYNDROME	0.013698599999999998	0.6819587093133154
WILSON DISEASE	0.013698599999999998	0.6819587093133154
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.013698599999999998	0.6819587093133154
DENT DISEASE 1	0.013698599999999998	0.6819587093133154
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.013698599999999998	0.6819587093133154
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.013698599999999998	0.6819587093133154
LOWE OCULOCEREBRORENAL SYNDROME	0.013698599999999998	0.6819587093133154
HEREDITARY OROTIC ACIDURIA	0.013698599999999998	0.6819587093133154
PHENYLKETONURIA	0.013698599999999998	0.6819587093133154
BETA-AMINOISOBUTYRIC ACID, URINARY EXCRETION OF	0.013698599999999998	0.6819587093133154
AMINO ACIDURIA WITH MENTAL DEFICIENCY, DWARFISM, MUSCULAR DYSTROPHY,OSTEOPOROSIS, AND ACIDOSIS	0.013698599999999998	0.6819587093133154
ICHTHYOSIS, SPLIT HAIRS, AND AMINO ACIDURIA	0.013698599999999998	0.6819587093133154
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.013698599999999998	0.6819587093133154
NEONATAL SEVERE PRIMARY HYPERPARATHYROIDISM	0.013698599999999998	0.6819587093133154
GALACTOSE EPIMERASE DEFICIENCY	0.013698599999999998	0.6819587093133154
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.013698599999999998	0.6819587093133154
ARGININOSUCCINIC ACIDURIA	0.013698599999999998	0.6819587093133154
ARGININOSUCCINIC ACIDURIA	0.013698599999999998	0.6819587093133154
DENT DISEASE	0.013698599999999998	0.6819587093133154
DERMOTRICHIC SYNDROME	0.013698599999999998	0.6819587093133154
TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, ANDOTHER ABNORMALITIES	0.013698599999999998	0.6819587093133154
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.013698599999999998	0.6819587093133154
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.013698599999999998	0.6819587093133154
NETHERTON SYNDROME	0.013698599999999998	0.6819587093133154
GALACTOSE EPIMERASE DEFICIENCY	0.013698599999999998	0.6819587093133154
TONNE-KALSCHEUER SYNDROME; TOKAS	0.013698040000000002	0.681930830779946
CHOREOACANTHOCYTOSIS	0.01368054	0.681059626612149
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.013216370000000002	0.6579518072655033
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.01315843	0.6550673747236658
KASABACH-MERRITT SYNDROME	0.01315679	0.6549857304473694
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.01315679	0.6549857304473694
EPISODIC ATAXIA TYPE 1	0.01315679	0.6549857304473694
STÜVE-WIEDEMANN SYNDROME	0.01315679	0.6549857304473694
ACTH-INDEPENDENT CUSHING SYNDROME	0.012916650000000002	0.6430308179413836
MELAS	0.012916650000000002	0.6430308179413836
ADIPOSIS DOLOROSA	0.012916650000000002	0.6430308179413836
ADIPOSIS DOLOROSA	0.01291665	0.6430308179413835
CUSHING SYNDROME DUE TO ECTOPIC ACTH SECRETION	0.01291665	0.6430308179413835
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.01290064	0.6422337905855876
STIFF PERSON SYNDROME AND RELATED DISORDERS	0.01261842	0.6281840054292647
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.012559810000000001	0.6252662182135746
NEURONAL CEROID LIPOFUSCINOSIS	0.012559810000000001	0.6252662182135746
SCLERODERMA	0.01231803	0.6132296614312922
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.01231803	0.6132296614312922
MENKES DISEASE	0.01231803	0.6132296614312922
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.01231803	0.6132296614312922
RHEUMATIC FEVER	0.01231803	0.6132296614312922
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.01231803	0.6132296614312922
PFAPA SYNDROME	0.01231803	0.6132296614312922
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.01213675	0.6042049819148221
ALEXANDER DISEASE	0.01213675	0.6042049819148221
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.01210488	0.6026183946675255
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4	0.01210488	0.6026183946675255
MYOTONIA FLUCTUANS	0.01210488	0.6026183946675255
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.01148019	0.5715193928628933
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.01123841	0.559482836080611
MALT LYMPHOMA	0.01123841	0.559482836080611
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.01123841	0.559482836080611
FAMILIAL COLD URTICARIA	0.01123841	0.559482836080611
SPONTANEOUS PERIODIC HYPOTHERMIA	0.01123841	0.559482836080611
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.01123841	0.559482836080611
TSH-SECRETING PITUITARY ADENOMA	0.01123841	0.559482836080611
NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA	0.01123841	0.559482836080611
CLASSIC HODGKIN LYMPHOMA	0.01123841	0.559482836080611
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.01123841	0.559482836080611
TAKAYASU ARTERITIS	0.01123841	0.559482836080611
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.01067281	0.5313255173774142
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.01067281	0.5313255173774142
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.01067281	0.5313255173774142
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.01067281	0.5313255173774142
CARDIOMYOPATHY-HYPOTONIA-LACTIC ACIDOSIS SYNDROME	0.01067281	0.5313255173774142
IATROGENIC BOTULISM	0.010442650000000001	0.519867440162549
JUVENILE DERMATOMYOSITIS	0.010442650000000001	0.519867440162549
INHALATIONAL BOTULISM	0.010442650000000001	0.519867440162549
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.010442650000000001	0.519867440162549
EVANS SYNDROME	0.010442650000000001	0.519867440162549
IDIOPATHIC/HERITABLE PULMONARY ARTERIAL HYPERTENSION	0.010442650000000001	0.519867440162549
WISKOTT-ALDRICH SYNDROME	0.010442650000000001	0.519867440162549
STEVENS-JOHNSON SYNDROME	0.010442650000000001	0.519867440162549
AUTOIMMUNE HEMOLYTIC ANEMIA, COLD TYPE	0.010442650000000001	0.519867440162549
THYMOMA	0.010442650000000001	0.519867440162549
HEPATOCELLULAR CARCINOMA	0.010442650000000001	0.519867440162549
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.010442650000000001	0.519867440162549
MIXED CONNECTIVE TISSUE DISEASE	0.010442650000000001	0.519867440162549
HUGHES-STOVIN SYNDROME	0.010442650000000001	0.519867440162549
LUJO HEMORRHAGIC FEVER	0.010442650000000001	0.519867440162549
ALPHA-THALASSEMIA-MYELODYSPLASTIC SYNDROME	0.010442650000000001	0.519867440162549
LYMPHANGIOLEIOMYOMATOSIS	0.010442650000000001	0.519867440162549
AL AMYLOIDOSIS	0.010442650000000001	0.519867440162549
REFRACTORY ANEMIA	0.010442650000000001	0.519867440162549
AUTOIMMUNE HEMOLYTIC ANEMIA	0.010442650000000001	0.519867440162549
SARCOIDOSIS	0.010442650000000001	0.519867440162549
ALPORT SYNDROME	0.010442650000000001	0.519867440162549
CASTLEMAN DISEASE	0.010442650000000001	0.519867440162549
AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS	0.010442650000000001	0.519867440162549
X-LINKED SIDEROBLASTIC ANEMIA	0.010442650000000001	0.519867440162549
HERMANSKY-PUDLAK SYNDROME	0.010442650000000001	0.519867440162549
PULMONARY ARTERIAL HYPERTENSION	0.010442650000000001	0.519867440162549
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.01013444	0.5045237923593094
SCHWARTZ-JAMPEL SYNDROME	0.01013444	0.5045237923593094
OROMANDIBULAR DYSTONIA	0.00990892	0.49329670870664866
PROGRESSIVE SUPRANUCLEAR PALSY-PARKINSONISM SYNDROME	0.00990892	0.49329670870664866
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.00965277	0.4805447688448668
CHILDHOOD ABSENCE EPILEPSY	0.00937055	0.4664949836885439
PORPHYRIA VARIEGATA	0.00937055	0.4664949836885439
PROGRESSIVE NON-FLUENT APHASIA	0.00937055	0.4664949836885439
SAGLIKER SYNDROME	0.00937055	0.4664949836885439
TURNER SYNDROME	0.00937055	0.4664949836885439
SPINOCEREBELLAR ATAXIA 12	0.00937055	0.4664949836885439
RAPID-ONSET DYSTONIA-PARKINSONISM	0.00937055	0.4664949836885439
CONGENITAL HYPOTHYROIDISM	0.00937055	0.4664949836885439
AUTOIMMUNE HEPATITIS	0.00937055	0.4664949836885439
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.00937055	0.4664949836885439
DYSTONIA 26, MYOCLONIC; DYT26	0.00937055	0.4664949836885439
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5	0.00937055	0.4664949836885439
DYSTONIA 12; DYT12	0.00937055	0.4664949836885439
MOSAIC MONOSOMY X	0.00937055	0.4664949836885439
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.00937055	0.4664949836885439
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.00937055	0.4664949836885439
ADULT-ONSET DISTAL MYOPATHY DUE TO VCP MUTATION	0.00937055	0.4664949836885439
MONOSOMY X	0.00937055	0.4664949836885439
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.00937055	0.4664949836885439
PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET	0.00937055	0.4664949836885439
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.00937055	0.4664949836885439
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.00937055	0.4664949836885439
USHER SYNDROME TYPE 3	0.00937055	0.4664949836885439
CREUTZFELDT-JAKOB DISEASE; CJD	0.00937055	0.4664949836885439
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.00937055	0.4664949836885439
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.00937055	0.4664949836885439
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.00937055	0.4664949836885439
USHER SYNDROME TYPE 2	0.00937055	0.4664949836885439
USHER SYNDROME TYPE 1	0.00937055	0.4664949836885439
XQ28 (MECP2) DUPLICATION	0.00937055	0.4664949836885439
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00937055	0.4664949836885439
TRISOMY X	0.00937055	0.4664949836885439
NORMOSMIC CONGENITAL HYPOGONADOTROPIC HYPOGONADISM	0.00937055	0.4664949836885439
WOLFRAM-LIKE SYNDROME	0.00937055	0.4664949836885439
FAMILIAL ALZHEIMER-LIKE PRION DISEASE	0.00937055	0.4664949836885439
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00937055	0.4664949836885439
48,XXYY SYNDROME	0.00937055	0.4664949836885439
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.00937055	0.4664949836885439
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.00937055	0.4664949836885439
3Q29 MICRODELETION SYNDROME	0.00937055	0.4664949836885439
ROLANDIC EPILEPSY	0.00937055	0.4664949836885439
YOUNG-ONSET PARKINSON DISEASE	0.00937055	0.4664949836885439
1Q21.1 MICRODELETION SYNDROME	0.00937055	0.4664949836885439
KOSAKI OVERGROWTH SYNDROME; KOGS	0.00937055	0.4664949836885439
CENTRAL DIABETES INSIPIDUS	0.00937055	0.4664949836885439
RABIES	0.00937055	0.4664949836885439
HEREDITARY COPROPORPHYRIA	0.00937055	0.4664949836885439
22Q11.2 DELETION SYNDROME	0.00937055	0.4664949836885439
INHERITED CREUTZFELDT-JAKOB DISEASE	0.00937055	0.4664949836885439
HUNTINGTON DISEASE-LIKE 2	0.00937055	0.4664949836885439
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.00937055	0.4664949836885439
HUNTINGTON DISEASE-LIKE SYNDROME DUE TO C9ORF72 EXPANSIONS	0.00937055	0.4664949836885439
AUTOSOMAL DOMINANT HYPOCALCEMIA	0.00937055	0.4664949836885439
WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	0.00937055	0.4664949836885439
HUNTINGTON DISEASE-LIKE 1	0.00937055	0.4664949836885439
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.00937055	0.4664949836885439
EPILEPSY, PYRIDOXINE-DEPENDENT	0.00925236	0.46061111965472
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.00925236	0.46061111965472
INHALATIONAL ANTHRAX	0.00901058	0.44857456287243763
NIPAH VIRUS DISEASE	0.00901058	0.44857456287243763
CRYPTOGENIC ORGANIZING PNEUMONIA	0.00901058	0.44857456287243763
TOXIC EPIDERMAL NECROLYSIS	0.00901058	0.44857456287243763
NOCARDIOSIS	0.00901058	0.44857456287243763
ARTERIAL TORTUOSITY SYNDROME	0.00901058	0.44857456287243763
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.00899621	0.44785917979293804
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.00899621	0.44785917979293804
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00899621	0.44785917979293804
XANTHINURIA, TYPE I	0.00899621	0.44785917979293804
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00899621	0.44785917979293804
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00899621	0.44785917979293804
MYOPATHY, SPHEROID BODY	0.00899621	0.44785917979293804
FINGERPRINT BODY MYOPATHY	0.00899621	0.44785917979293804
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.00877193	0.4366938271784526
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.00877193	0.4366938271784526
ABETA AMYLOIDOSIS, DUTCH TYPE	0.00877193	0.4366938271784526
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00877193	0.4366938271784526
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.00877193	0.4366938271784526
LOCKED-IN SYNDROME	0.00877193	0.4366938271784526
CAFFEY DISEASE	0.00877193	0.4366938271784526
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.00877193	0.4366938271784526
1Q41Q42 MICRODELETION SYNDROME	0.00877193	0.4366938271784526
PINEOBLASTOMA	0.00877193	0.4366938271784526
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00877193	0.4366938271784526
INFANTILE REFSUM DISEASE	0.00877193	0.4366938271784526
KEIPERT SYNDROME	0.00877193	0.4366938271784526
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.00877193	0.4366938271784526
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.00877193	0.4366938271784526
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.00877193	0.4366938271784526
ANGELMAN SYNDROME	0.00877193	0.4366938271784526
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.00877193	0.4366938271784526
MONOAMINE OXIDASE A DEFICIENCY	0.00877193	0.4366938271784526
ABETAL34V AMYLOIDOSIS	0.00877193	0.4366938271784526
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.00877193	0.4366938271784526
ABETA AMYLOIDOSIS, IOWA TYPE	0.00877193	0.4366938271784526
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.00877193	0.4366938271784526
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.00877193	0.4366938271784526
NANCE-HORAN SYNDROME	0.00877193	0.4366938271784526
METACHROMATIC LEUKODYSTROPHY	0.00877193	0.4366938271784526
LESCH-NYHAN SYNDROME	0.00877193	0.4366938271784526
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.00877193	0.4366938271784526
SPINOCEREBELLAR ATAXIA TYPE 38	0.00877193	0.4366938271784526
9Q33.3Q34.11 MICRODELETION SYNDROME	0.00877193	0.4366938271784526
CORTICOBASAL SYNDROME	0.00877193	0.4366938271784526
20Q11.2 MICRODELETION SYNDROME	0.00877193	0.4366938271784526
NEUROCUTANEOUS MELANOCYTOSIS	0.00877193	0.4366938271784526
L-2-HYDROXYGLUTARIC ACIDURIA	0.00877193	0.4366938271784526
INDOLENT SYSTEMIC MASTOCYTOSIS	0.00877193	0.4366938271784526
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.00877193	0.4366938271784526
ISOLATED CEREBELLAR AGENESIS	0.00877193	0.4366938271784526
SPINOCEREBELLAR ATAXIA TYPE 21	0.00877193	0.4366938271784526
SPINOCEREBELLAR ATAXIA TYPE 12	0.00877193	0.4366938271784526
SPINOCEREBELLAR ATAXIA TYPE 17	0.00877193	0.4366938271784526
NEUROFERRITINOPATHY	0.00877193	0.4366938271784526
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.00877193	0.4366938271784526
MONOSOMY 18P	0.00877193	0.4366938271784526
FAMILIAL PAROXYSMAL ATAXIA	0.00877193	0.4366938271784526
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.00877193	0.4366938271784526
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.00877193	0.4366938271784526
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.00877193	0.4366938271784526
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.00877193	0.4366938271784526
MILROY DISEASE	0.00877193	0.4366938271784526
FETAL ALCOHOL SYNDROME	0.00877193	0.4366938271784526
DEAFNESS-HYPOGONADISM SYNDROME	0.00877193	0.4366938271784526
HEREDITARY FOLATE MALABSORPTION	0.00877193	0.4366938271784526
ADULT POLYGLUCOSAN BODY DISEASE	0.00877193	0.4366938271784526
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.00877193	0.4366938271784526
HSD10 DISEASE, ATYPICAL TYPE	0.00877193	0.4366938271784526
MALE HYPERGONADOTROPIC HYPOGONADISM-INTELLECTUAL DISABILITY-SKELETAL ANOMALIES SYNDROME	0.00877193	0.4366938271784526
5Q35 MICRODUPLICATION SYNDROME	0.00877193	0.4366938271784526
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.00877193	0.4366938271784526
SNEDDON SYNDROME	0.00877193	0.4366938271784526
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.00877193	0.4366938271784526
HUNTINGTON DISEASE	0.00877193	0.4366938271784526
SOTOS SYNDROME	0.00877193	0.4366938271784526
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.00877193	0.4366938271784526
MENTAL RETARDATION, X-LINKED 90	0.00877193	0.4366938271784526
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.00877193	0.4366938271784526
WHITE-SUTTON SYNDROME; WHSUS	0.00877193	0.4366938271784526
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.00877193	0.4366938271784526
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.00877193	0.4366938271784526
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.00877193	0.4366938271784526
WEAVER SYNDROME	0.00877193	0.4366938271784526
MENTAL RETARDATION, X-LINKED 105; MRX105	0.00877193	0.4366938271784526
LANDAU-KLEFFNER SYNDROME	0.00877193	0.4366938271784526
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.00877193	0.4366938271784526
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.00877193	0.4366938271784526
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.00877193	0.4366938271784526
CORNELIA DE LANGE SYNDROME 1	0.00877193	0.4366938271784526
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.00877193	0.4366938271784526
BREATH-HOLDING SPELLS	0.00877193	0.4366938271784526
2Q33.1 DELETION SYNDROME	0.00877193	0.4366938271784526
MYHRE SYNDROME	0.00877193	0.4366938271784526
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.00877193	0.4366938271784526
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, MYOPATHIC FORM	0.00875443	0.43582262301065566
PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE	0.00875443	0.43582262301065566
EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY	0.00875443	0.43582262301065566
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.00875443	0.43582262301065566
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.00847221	0.4217728378543329
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.00823232	0.4098303711221726
PERRY SYNDROME	0.00823232	0.4098303711221726
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	0.00799054	0.39779381433989025
PRIMARY SCLEROSING CHOLANGITIS	0.00799054	0.39779381433989025
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.00799054	0.39779381433989025
CUSHING SYNDROME DUE TO MACRONODULAR ADRENAL HYPERPLASIA	0.00799054	0.39779381433989025
CENTRAL CONGENITAL HYPOTHYROIDISM	0.00799054	0.39779381433989025
WHIPPLE DISEASE	0.00799054	0.39779381433989025
GAUCHER DISEASE	0.00799054	0.39779381433989025
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00799054	0.39779381433989025
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2	0.00799054	0.39779381433989025
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.00769231	0.3829470018277714
BUERGER DISEASE	0.00769231	0.3829470018277714
CRISPONI SYNDROME	0.00769231	0.3829470018277714
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.00769231	0.3829470018277714
PACHYDERMOPERIOSTOSIS	0.00769231	0.3829470018277714
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.00769231	0.3829470018277714
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.00769231	0.3829470018277714
SANDHOFF DISEASE	0.00769231	0.3829470018277714
NAXOS DISEASE	0.00769231	0.3829470018277714
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.00769231	0.3829470018277714
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.00769231	0.3829470018277714
FUCOSIDOSIS	0.00769231	0.3829470018277714
OSTEOGENESIS IMPERFECTA	0.00769231	0.3829470018277714
PALMOPLANTAR KERATODERMA, NAGASHIMA TYPE	0.00769231	0.3829470018277714
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.00769231	0.3829470018277714
SILVER-RUSSELL SYNDROME	0.00769231	0.3829470018277714
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.00769231	0.3829470018277714
ISAAC SYNDROME	0.00769231	0.3829470018277714
PACHYONYCHIA CONGENITA	0.00769231	0.3829470018277714
TYROSINEMIA TYPE 2	0.00769231	0.3829470018277714
CLUSTER HEADACHE, FAMILIAL	0.00769231	0.3829470018277714
DYSKERATOSIS CONGENITA	0.00769231	0.3829470018277714
PITUITARY GIGANTISM	0.00769231	0.3829470018277714
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.00769231	0.3829470018277714
PHEOCHROMOCYTOMA	0.00769231	0.3829470018277714
%613576 ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 2; EDSS2	0.00769231	0.3829470018277714
VON HIPPEL-LINDAU DISEASE	0.00769231	0.3829470018277714
PHEOCHROMOCYTOMA--ISLET CELL TUMOR SYNDROME	0.00769231	0.3829470018277714
CHONDROECTODERMAL DYSPLASIA WITH NIGHT BLINDNESS	0.00769231	0.3829470018277714
GRANULOSIS RUBRA NASI	0.00769231	0.3829470018277714
X-LINKED ACROGIGANTISM	0.00769231	0.3829470018277714
SPASTIC PARAPLEGIA-OPTIC ATROPHY-NEUROPATHY SYNDROME	0.00769231	0.3829470018277714
MAL DE MELEDA	0.00769231	0.3829470018277714
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.00769231	0.3829470018277714
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL DOMINANT	0.00769231	0.3829470018277714
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.00769231	0.3829470018277714
118301 CHARCOT-MARIE-TOOTH DISEASE WITH PTOSIS AND PARKINSONISM	0.00769231	0.3829470018277714
KERATOSIS PALMARIS ET PLANTARIS-CLINODACTYLY SYNDROME	0.00769231	0.3829470018277714
PEDIATRIC-ONSET GRAVES DISEASE	0.00769231	0.3829470018277714
ACROKERATOELASTOIDOSIS OF COSTA	0.00769231	0.3829470018277714
MEDULLARY THYROID CARCINOMA	0.00769231	0.3829470018277714
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	0.00769231	0.3829470018277714
NAKAJO-NISHIMURA SYNDROME	0.00769231	0.3829470018277714
FAMILIAL TUMORAL CALCINOSIS	0.00769231	0.3829470018277714
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.00769231	0.3829470018277714
MOTOR NEUROPATHY, PERIPHERAL, WITH DYSAUTONOMIA	0.00769231	0.3829470018277714
TUFTED ANGIOMA	0.00769231	0.3829470018277714
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.00769231	0.3829470018277714
LOCALIZED EPIDERMOLYSIS BULLOSA SIMPLEX	0.00769231	0.3829470018277714
BUERGER DISEASE	0.00769231	0.3829470018277714
INCONTINENTIA PIGMENTI	0.00769231	0.3829470018277714
MAL DE MELEDA	0.00769231	0.3829470018277714
MONOSOMY 22	0.00769231	0.3829470018277714
PALMOPLANTAR KERATODERMA I, STRIATE, FOCAL, OR DIFFUSE; PPKS1	0.00769231	0.3829470018277714
FOCAL PALMOPLANTAR AND GINGIVAL KERATODERMA	0.00769231	0.3829470018277714
FAMILIAL THROMBOCYTOSIS	0.00769231	0.3829470018277714
GANGLIOCYTOMA	0.00769231	0.3829470018277714
ANTERIOR CUTANEOUS NERVE ENTRAPMENT SYNDROME	0.00769231	0.3829470018277714
TRANSGREDIENS ET PROGREDIENS PALMOPLANTAR KERATODERMA	0.00769231	0.3829470018277714
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 2	0.00769231	0.3829470018277714
HYPERHIDROSIS, GUSTATORY	0.00769231	0.3829470018277714
NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE	0.00769231	0.3829470018277714
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.00769231	0.3829470018277714
KERATOLYTIC WINTER ERYTHEMA	0.00769231	0.3829470018277714
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.00769231	0.3829470018277714
NOONAN SYNDROME 7; NS7	0.00769231	0.3829470018277714
ANGIOKERATOMA CORPORIS DIFFUSUM WITH ARTERIOVENOUS FISTULAS	0.00769231	0.3829470018277714
EPIDERMOLYTIC PALMOPLANTAR KERATODERMA	0.00769231	0.3829470018277714
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED INTERMEDIATE	0.00769231	0.3829470018277714
BÖÖK SYNDROME	0.00769231	0.3829470018277714
BLOOM SYNDROME	0.00769231	0.3829470018277714
PERIPHERAL MOTOR NEUROPATHY-DYSAUTONOMIA SYNDROME	0.00769231	0.3829470018277714
ODONTOONYCHODERMAL DYSPLASIA; OODD	0.00769231	0.3829470018277714
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.00769231	0.3829470018277714
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.00769231	0.3829470018277714
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.00733398	0.3651082252879615
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.00689655	0.34333160590970946
PULMONARY ALVEOLAR PROTEINOSIS, ACQUIRED	0.00689655	0.34333160590970946
ADULT INTESTINAL BOTULISM	0.00689655	0.34333160590970946
INTESTINAL BOTULISM	0.00689655	0.34333160590970946
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 13; CMH13	0.00689655	0.34333160590970946
INFANT BOTULISM	0.00689655	0.34333160590970946
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.00689655	0.34333160590970946
WOUND BOTULISM	0.00689655	0.34333160590970946
CREST SYNDROME	0.00689655	0.34333160590970946
SOLAR URTICARIA	0.00689655	0.34333160590970946
PULMONARY BLASTOMA	0.00689655	0.34333160590970946
CARDIONEUROMYOPATHY WITH HYALINE MASSES AND NEMALINE RODS	0.00689655	0.34333160590970946
PAROXYSMAL NON-KINESIGENIC DYSKINESIA	0.00689655	0.34333160590970946
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1E	0.00689655	0.34333160590970946
TOXIN-MEDIATED INFECTIOUS BOTULISM	0.00689655	0.34333160590970946
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.00689655	0.34333160590970946
BRONCHIAL NEUROENDOCRINE TUMOR	0.00689655	0.34333160590970946
BLAU SYNDROME	0.00689655	0.34333160590970946
KLEEFSTRA SYNDROME	0.00689655	0.34333160590970946
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 10; CMH10	0.00689655	0.34333160590970946
DRUG-INDUCED LUPUS ERYTHEMATOSUS	0.00689655	0.34333160590970946
LARYNGOTRACHEOESOPHAGEAL CLEFT	0.00689655	0.34333160590970946
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.00689655	0.34333160590970946
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 4; HHT4	0.00689655	0.34333160590970946
PULMONARY ARTERIOVENOUS MALFORMATION	0.00689655	0.34333160590970946
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.00689655	0.34333160590970946
MYASTHENIA GRAVIS	0.00689655	0.34333160590970946
FAMILIAL DILATED CARDIOMYOPATHY	0.00689655	0.34333160590970946
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.00689655	0.34333160590970946
IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION	0.00689655	0.34333160590970946
LARYNGEAL ABDUCTOR PARALYSIS WITH CEREBELLAR ATAXIA AND MOTOR NEUROPATHY	0.00689655	0.34333160590970946
NIEMANN-PICK DISEASE, TYPE B	0.00689655	0.34333160590970946
DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS	0.00689655	0.34333160590970946
SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2	0.00689655	0.34333160590970946
PULMONARY FIBROSIS-HEPATIC HYPERPLASIA-BONE MARROW HYPOPLASIA SYNDROME	0.00689655	0.34333160590970946
IDIOPATHIC BRONCHIECTASIS	0.00689655	0.34333160590970946
GLYCOGEN STORAGE DISEASE II	0.00689655	0.34333160590970946
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 15	0.00689655	0.34333160590970946
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.00689655	0.34333160590970946
CHRONIC GRAFT VERSUS HOST DISEASE	0.00689655	0.34333160590970946
219400 CYANOSIS AND HEPATIC DISEASE	0.00689655	0.34333160590970946
AMERICAN TRYPANOSOMIASIS	0.00689655	0.34333160590970946
PRIMARY HEPATIC NEUROENDOCRINE CARCINOMA	0.00689655	0.34333160590970946
TRACHEOPATHIA OSTEOPLASTICA	0.00689655	0.34333160590970946
LETTERER-SIWE DISEASE	0.00689655	0.34333160590970946
JOUBERT SYNDROME 21	0.00689655	0.34333160590970946
GAUCHER DISEASE, TYPE I	0.00689655	0.34333160590970946
PRIMARY EFFUSION LYMPHOMA	0.00689655	0.34333160590970946
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS	0.00689655	0.34333160590970946
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.00689655	0.34333160590970946
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.00689655	0.34333160590970946
THYMIC TUMOR	0.00689655	0.34333160590970946
RELAPSING POLYCHONDRITIS	0.00689655	0.34333160590970946
PYRUVATE DEHYDROGENASE DEFICIENCY	0.00689655	0.34333160590970946
ANEURYSM OF SINUS OF VALSALVA	0.00689655	0.34333160590970946
MACULOPAPULAR CUTANEOUS MASTOCYTOSIS	0.00689655	0.34333160590970946
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED SEVERE	0.00689655	0.34333160590970946
KEPPEN-LUBINSKY SYNDROME	0.00689655	0.34333160590970946
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 26; CMH26	0.00689655	0.34333160590970946
ARIMA SYNDROME	0.00689655	0.34333160590970946
ADULT ACUTE RESPIRATORY DISTRESS SYNDROME	0.00689655	0.34333160590970946
ACUTE MYELOMONOCYTIC LEUKEMIA	0.00689655	0.34333160590970946
ALPHA-1-ANTITRYPSIN DEFICIENCY; A1ATD	0.00689655	0.34333160590970946
GOODPASTURE SYNDROME	0.00689655	0.34333160590970946
GOOD SYNDROME	0.00689655	0.34333160590970946
MALIGNANT PERITONEAL MESOTHELIOMA	0.00689655	0.34333160590970946
MEIER-GORLIN SYNDROME 3; MGORS3	0.00689655	0.34333160590970946
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 17; CMH17	0.00689655	0.34333160590970946
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.00689655	0.34333160590970946
SIALIDOSIS TYPE 2	0.00689655	0.34333160590970946
YELLOW NAIL SYNDROME	0.00689655	0.34333160590970946
GLUTAMATE MONOSODIUM SENSITIVITY	0.00689655	0.34333160590970946
FAMILIAL PROGRESSIVE CARDIAC CONDUCTION DEFECT	0.00689655	0.34333160590970946
MYOTONIA PERMANENS	0.00689655	0.34333160590970946
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.00546448	0.27203872861959805
DIAPHANOSPONDYLODYSOSTOSIS	0.00546448	0.27203872861959805
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.00546448	0.27203872861959805
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.00546448	0.27203872861959805
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.00546448	0.27203872861959805
PROGRESSIVE SUPRANUCLEAR PALSY-CORTICOBASAL SYNDROME	0.00546448	0.27203872861959805
GAUCHER DISEASE TYPE 2	0.00546448	0.27203872861959805
CONGENITAL PULMONARY LYMPHANGIECTASIA	0.00546448	0.27203872861959805
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.00546448	0.27203872861959805
EAR-PATELLA-SHORT STATURE SYNDROME	0.00546448	0.27203872861959805
LARYNGEAL WEB, FAMILIAL	0.00546448	0.27203872861959805
PRIMARY CILIARY DYSKINESIA	0.00546448	0.27203872861959805
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.00546448	0.27203872861959805
LARYNGOMALACIA	0.00546448	0.27203872861959805
MALARIA	0.00546448	0.27203872861959805
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.00546448	0.27203872861959805
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.00546448	0.27203872861959805
KNIEST DYSPLASIA	0.00546448	0.27203872861959805
CONGENITAL LARYNGEAL WEB	0.00546448	0.27203872861959805
PLEURAL MESOTHELIOMA	0.00546448	0.27203872861959805
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.00546448	0.27203872861959805
SLC35A1-CDG	0.00546448	0.27203872861959805
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.00546448	0.27203872861959805
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.00546448	0.27203872861959805
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00546448	0.27203872861959805
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.00546448	0.27203872861959805
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.00546448	0.27203872861959805
HEREDITARY PULMONARY ALVEOLAR PROTEINOSIS	0.00546448	0.27203872861959805
AGNATHIA-OTOCEPHALY COMPLEX	0.00546448	0.27203872861959805
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.00546448	0.27203872861959805
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.00546448	0.27203872861959805
TETRASOMY 5P	0.00546448	0.27203872861959805
MERCURY POISONING	0.00546448	0.27203872861959805
TETANUS	0.00546448	0.27203872861959805
PFEIFFER SYNDROME TYPE 3	0.00546448	0.27203872861959805
RECURRENT ACUTE PANCREATITIS	0.00546448	0.27203872861959805
PFEIFFER SYNDROME TYPE 2	0.00546448	0.27203872861959805
FAMILIAL NASAL ACILIA	0.00546448	0.27203872861959805
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.00546448	0.27203872861959805
ODONTOCHONDRODYSPLASIA; ODCD	0.00546448	0.27203872861959805
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.00546448	0.27203872861959805
CONGENITAL ENTEROVIRUS INFECTION	0.00546448	0.27203872861959805
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.00546448	0.27203872861959805
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.00546448	0.27203872861959805
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 1	0.00546448	0.27203872861959805
RADIO-RENAL SYNDROME	0.00546448	0.27203872861959805
COLCHICINE POISONING	0.00546448	0.27203872861959805
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.00546448	0.27203872861959805
SPONDYLOEPIMETAPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE	0.00546448	0.27203872861959805
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.00546448	0.27203872861959805
PMM2-CDG	0.00546448	0.27203872861959805
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.00546448	0.27203872861959805
SUCCINIC ACIDEMIA	0.00546448	0.27203872861959805
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.00546448	0.27203872861959805
PRADER-WILLI-LIKE SYNDROME	0.00546448	0.27203872861959805
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.00546448	0.27203872861959805
STT3B-CDG	0.00546448	0.27203872861959805
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.00546448	0.27203872861959805
HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	0.00546448	0.27203872861959805
MYOTONIC DYSTROPHY 1	0.00546448	0.27203872861959805
HYPOMYELINATION NEUROPATHY-ARTHROGRYPOSIS SYNDROME	0.00546448	0.27203872861959805
ULBRIGHT-HODES SYNDROME	0.00546448	0.27203872861959805
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.00546448	0.27203872861959805
DOORS SYNDROME	0.00546448	0.27203872861959805
SCHINZEL-GIEDION SYNDROME	0.00546448	0.27203872861959805
STEINERT MYOTONIC DYSTROPHY	0.00546448	0.27203872861959805
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.00546448	0.27203872861959805
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00546448	0.27203872861959805
RECURRENT RESPIRATORY PAPILLOMATOSIS	0.00546448	0.27203872861959805
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.00546448	0.27203872861959805
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.00546448	0.27203872861959805
MOEBIUS SYNDROME; MBS	0.00546448	0.27203872861959805
MEIER-GORLIN SYNDROME 1; MGORS1	0.00546448	0.27203872861959805
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.00546448	0.27203872861959805
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.00546448	0.27203872861959805
LYMPHATIC MALFORMATION 7; LMPHM7	0.00546448	0.27203872861959805
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.00546448	0.27203872861959805
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.00546448	0.27203872861959805
CRYPTOSPORIDIOSIS	0.00546448	0.27203872861959805
CONGENITAL DIAPHRAGMATIC HERNIA	0.00546448	0.27203872861959805
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.00546448	0.27203872861959805
CAMPOMELIC DYSPLASIA	0.00546448	0.27203872861959805
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.00546448	0.27203872861959805
LETHAL RECESSIVE CHONDRODYSPLASIA	0.00546448	0.27203872861959805
ANAPLASTIC THYROID CARCINOMA	0.00546448	0.27203872861959805
RAMOS-ARROYO SYNDROME	0.00546448	0.27203872861959805
EMPHYSEMA, CONGENITAL LOBAR	0.00546448	0.27203872861959805
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.00546448	0.27203872861959805
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.00546448	0.27203872861959805
DIAPHANOSPONDYLODYSOSTOSIS	0.00546448	0.27203872861959805
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00546448	0.27203872861959805
CONGENITAL ALVEOLAR CAPILLARY DYSPLASIA	0.00546448	0.27203872861959805
CHITAYAT SYNDROME	0.00546448	0.27203872861959805
ODONTOCHONDRODYSPLASIA	0.00546448	0.27203872861959805
HYPOGLOSSIA WITH SITUS INVERSUS	0.00546448	0.27203872861959805
LETHAL OSTEOSCLEROTIC BONE DYSPLASIA	0.00546448	0.27203872861959805
OSTEOMYELITIS, STERILE MULTIFOCAL, WITH PERIOSTITIS AND PUSTULOSIS; OMPP	0.00546448	0.27203872861959805
HEREDITARY ANGIOEDEMA TYPE 1	0.00546448	0.27203872861959805
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.00546448	0.27203872861959805
CLEIDOCRANIAL DYSPLASIA; CCD	0.00546448	0.27203872861959805
AGNATHIA-HOLOPROSENCEPHALY-SITUS INVERSUS SYNDROME	0.00546448	0.27203872861959805
CONGENITAL LOBAR EMPHYSEMA	0.00546448	0.27203872861959805
DIAMOND-BLACKFAN ANEMIA 10	0.00546448	0.27203872861959805
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.00546448	0.27203872861959805
MICROCEPHALY-POLYMICROGYRIA-CORPUS CALLOSUM AGENESIS SYNDROME	0.00546448	0.27203872861959805
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00546448	0.27203872861959805
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.00546448	0.27203872861959805
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.00546448	0.27203872861959805
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00546448	0.27203872861959805
DESBUQUOIS DYSPLASIA 2; DBQD2	0.00546448	0.27203872861959805
PRIMARY DYSTONIA, DYT4 TYPE	0.00546448	0.27203872861959805
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.00546448	0.27203872861959805
GAUCHER DISEASE, PERINATAL LETHAL	0.00546448	0.27203872861959805
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.00546448	0.27203872861959805
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.00546448	0.27203872861959805
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.00546448	0.27203872861959805
BARDET-BIEDL SYNDROME 16; BBS16	0.00546448	0.27203872861959805
CHOANAL ATRESIA	0.00546448	0.27203872861959805
THYROID LYMPHOMA	0.00546448	0.27203872861959805
AUTOIMMUNE INTERSTITIAL LUNG, JOINT, AND KIDNEY DISEASE; AILJK	0.00546448	0.27203872861959805
ISOLATED ARRHINIA	0.00546448	0.27203872861959805
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.00546448	0.27203872861959805
ACETYL-COA CARBOXYLASE DEFICIENCY	0.00520833	0.25928678875781613
MYOPATHY, DISTAL, 4; MPD4	0.00520833	0.25928678875781613
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN	0.00520833	0.25928678875781613
VACUOLAR MYOPATHY WITH SARCOPLASMIC RETICULUM PROTEIN AGGREGATES	0.00520833	0.25928678875781613
BETHLEM MYOPATHY 2; BTHLM2	0.00520833	0.25928678875781613
MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A	0.00520833	0.25928678875781613
ADDUCTED THUMBS SYNDROME	0.00520833	0.25928678875781613
COMBINED IMMUNODEFICIENCY DUE TO CRAC CHANNEL DYSFUNCTION	0.00520833	0.25928678875781613
TYPICAL NEMALINE MYOPATHY	0.00520833	0.25928678875781613
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.00520833	0.25928678875781613
HYPOKALEMIC PERIODIC PARALYSIS, TYPE 2; HOKPP2	0.00520833	0.25928678875781613
MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS2C	0.00520833	0.25928678875781613
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.00520833	0.25928678875781613
GLYCEROL KINASE DEFICIENCY; GKD	0.00520833	0.25928678875781613
CARCINOID SYNDROME	0.00520833	0.25928678875781613
PLEOCONIAL MYOPATHY WITH SALT CRAVING	0.00520833	0.25928678875781613
B4GALT1-CDG	0.00520833	0.25928678875781613
1P36 DELETION SYNDROME	0.00520833	0.25928678875781613
MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A	0.00520833	0.25928678875781613
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.00520833	0.25928678875781613
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2CC; CMT2CC	0.00520833	0.25928678875781613
AXIAL OSTEOMALACIA	0.00520833	0.25928678875781613
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.00520833	0.25928678875781613
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.00520833	0.25928678875781613
ANAL SPHINCTER MYOPATHY, INTERNAL	0.00520833	0.25928678875781613
IMMUNODEFICIENCY 9; IMD9	0.00520833	0.25928678875781613
ISOLATED GLYCEROL KINASE DEFICIENCY	0.00520833	0.25928678875781613
STROMME SYNDROME; STROMS	0.00520833	0.25928678875781613
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO FKBP22 DEFICIENCY	0.00520833	0.25928678875781613
CARNITINE DEFICIENCY, MYOPATHIC	0.00520833	0.25928678875781613
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.00520833	0.25928678875781613
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.00520833	0.25928678875781613
DIAPHYSEAL MEDULLARY STENOSIS WITH MALIGNANT FIBROUS HISTIOCYTOMA; DMSMFH	0.00520833	0.25928678875781613
STORMORKEN SYNDROME; STRMK	0.00520833	0.25928678875781613
SANJAD-SAKATI SYNDROME	0.00520833	0.25928678875781613
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.00520833	0.25928678875781613
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 3; IBMPFD3	0.00520833	0.25928678875781613
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.00520833	0.25928678875781613
MYOPATHY DUE TO MALATE-ASPARTATE SHUTTLE DEFECT	0.00520833	0.25928678875781613
WOLFRAM SYNDROME	0.00520833	0.25928678875781613
ACQUIRED PARTIAL LIPODYSTROPHY	0.00520833	0.25928678875781613
GLYCOGEN STORAGE DISEASE DUE TO MUSCLE GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.00520833	0.25928678875781613
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN DEBRANCHING ENZYME DEFICIENCY	0.00520833	0.25928678875781613
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.00520833	0.25928678875781613
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.00520833	0.25928678875781613
CONGENITAL MYASTHENIC SYNDROMES WITH GLYCOSYLATION DEFECT	0.00520833	0.25928678875781613
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00520833	0.25928678875781613
FAMILIAL ISOLATED DILATED CARDIOMYOPATHY	0.00520833	0.25928678875781613
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.00520833	0.25928678875781613
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.00520833	0.25928678875781613
LEBER HEREDITARY OPTIC NEUROPATHY	0.00520833	0.25928678875781613
CHANARIN-DORFMAN SYNDROME	0.00520833	0.25928678875781613
CONGENITAL CATARACT-HYPERTROPHIC CARDIOMYOPATHY-MITOCHONDRIAL MYOPATHY SYNDROME	0.00520833	0.25928678875781613
PPARG-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.00520833	0.25928678875781613
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.00520833	0.25928678875781613
ACQUIRED GENERALIZED LIPODYSTROPHY	0.00520833	0.25928678875781613
CARDIOMYOPATHY ASSOCIATED WITH MYOPATHY AND SUDDEN DEATH	0.00520833	0.25928678875781613
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.00520833	0.25928678875781613
CAREY-FINEMAN-ZITER SYNDROME	0.00520833	0.25928678875781613
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.00520833	0.25928678875781613
MARINESCO-SJOGREN SYNDROME; MSS	0.00520833	0.25928678875781613
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.00520833	0.25928678875781613
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.00520833	0.25928678875781613
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.00520833	0.25928678875781613
MYOPATHY, DISTAL, 5; MPD5	0.00520833	0.25928678875781613
BETA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R4	0.00520833	0.25928678875781613
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 3	0.00520833	0.25928678875781613
BETHLEM MYOPATHY 1	0.00520833	0.25928678875781613
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.00520833	0.25928678875781613
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.00520833	0.25928678875781613
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 2	0.00520833	0.25928678875781613
XP21 MICRODELETION SYNDROME	0.00520833	0.25928678875781613
DUCHENNE AND BECKER MUSCULAR DYSTROPHY	0.00520833	0.25928678875781613
MUSCULAR DYSTROPHY, BARNES TYPE	0.00520833	0.25928678875781613
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.00520833	0.25928678875781613
LIMB-GIRDLE MUSCULAR DYSTROPHY, TYPE 1G; LGMD1G	0.00520833	0.25928678875781613
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00520833	0.25928678875781613
MYOPATHY WITH STORAGE OF GLYCOPROTEINS AND GLYCOSAMINOGLYCANS	0.00520833	0.25928678875781613
OCULOPHARYNGEAL MUSCULAR DYSTROPHY	0.00520833	0.25928678875781613
CENTRAL CORE DISEASE	0.00520833	0.25928678875781613
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.00520833	0.25928678875781613
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.00520833	0.25928678875781613
HYPERKALEMIC PERIODIC PARALYSIS	0.00520833	0.25928678875781613
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.00520833	0.25928678875781613
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.00520833	0.25928678875781613
MUSCULAR ATROPHY-ATAXIA-RETINITIS PIGMENTOSA-DIABETES MELLITUS SYNDROME	0.00520833	0.25928678875781613
MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA	0.00520833	0.25928678875781613
MERRF	0.00520833	0.25928678875781613
RIGID SPINE SYNDROME	0.00520833	0.25928678875781613
ADRENOMYODYSTROPHY	0.00520833	0.25928678875781613
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.00520833	0.25928678875781613
MYOPATHY, DISTAL, WITH ANTERIOR TIBIAL ONSET; DMAT	0.00520833	0.25928678875781613
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.00520833	0.25928678875781613
MARINESCO-SJÖGREN SYNDROME	0.00520833	0.25928678875781613
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4	0.00520833	0.25928678875781613
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.00520833	0.25928678875781613
X-LINKED IMMUNONEUROLOGIC DISORDER	0.00520833	0.25928678875781613
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.00520833	0.25928678875781613
MUSCLE-EYE-BRAIN DISEASE	0.00520833	0.25928678875781613
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.00520833	0.25928678875781613
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.00520833	0.25928678875781613
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.00520833	0.25928678875781613
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.00520833	0.25928678875781613
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.00520833	0.25928678875781613
DISTAL MYOPATHY	0.00520833	0.25928678875781613
MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE	0.00520833	0.25928678875781613
FAMILIAL PARTIAL LIPODYSTROPHY, DUNNIGAN TYPE	0.00520833	0.25928678875781613
EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED; EDMD1	0.00520833	0.25928678875781613
AUTOSOMAL SEMI-DOMINANT SEVERE LIPODYSTROPHIC LAMINOPATHY	0.00520833	0.25928678875781613
TRIM32-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R8	0.00520833	0.25928678875781613
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.00520833	0.25928678875781613
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.00520833	0.25928678875781613
HYPOPHOSPHATASIA, CHILDHOOD	0.00520833	0.25928678875781613
OCULOGASTROINTESTINAL MUSCULAR DYSTROPHY	0.00520833	0.25928678875781613
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.00520833	0.25928678875781613
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.00520833	0.25928678875781613
MYOPATHY, MITOCHONDRIAL, LETHAL INFANTILE	0.00520833	0.25928678875781613
PRIMARY LIPODYSTROPHY	0.00520833	0.25928678875781613
NEUTRAL LIPID STORAGE MYOPATHY	0.00520833	0.25928678875781613
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.00520833	0.25928678875781613
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.00520833	0.25928678875781613
SALIH MYOPATHY; SALMY	0.00520833	0.25928678875781613
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.00520833	0.25928678875781613
VICI SYNDROME; VICIS	0.00520833	0.25928678875781613
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.00492611	0.24523700360149334
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.00492611	0.24523700360149334
CHILDHOOD-ONSET BENIGN CHOREA WITH STRIATAL INVOLVEMENT	0.00492611	0.24523700360149334
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.00492611	0.24523700360149334
7Q11.23 MICRODUPLICATION SYNDROME	0.00492611	0.24523700360149334
DISTAL MONOSOMY 10Q	0.00492611	0.24523700360149334
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.00492611	0.24523700360149334
POSTERIOR CORTICAL ATROPHY	0.00492611	0.24523700360149334
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.00492611	0.24523700360149334
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.00492611	0.24523700360149334
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.00492611	0.24523700360149334
48,XXXY SYNDROME	0.00492611	0.24523700360149334
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.00492611	0.24523700360149334
PANIC DISORDER 1	0.00492611	0.24523700360149334
TENORIO SYNDROME; TNORS	0.00492611	0.24523700360149334
RENPENNING SYNDROME 1; RENS1	0.00492611	0.24523700360149334
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.00492611	0.24523700360149334
SPINOCEREBELLAR ATAXIA 48; SCA48	0.00492611	0.24523700360149334
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.00492611	0.24523700360149334
2Q32Q33 MICRODELETION SYNDROME	0.00492611	0.24523700360149334
WILLIAMS-BEUREN SYNDROME; WBS	0.00492611	0.24523700360149334
RUBINSTEIN-TAYBI SYNDROME	0.00492611	0.24523700360149334
HYPERTELORISM, TEEBI TYPE; TBHS	0.00492611	0.24523700360149334
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.00492611	0.24523700360149334
GABRIELE-DE VRIES SYNDROME	0.00492611	0.24523700360149334
XP22.13P22.2 DUPLICATION SYNDROME	0.00492611	0.24523700360149334
PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET	0.00492611	0.24523700360149334
SMITH-MAGENIS SYNDROME	0.00492611	0.24523700360149334
GM2 GANGLIOSIDOSIS, AB VARIANT	0.00492611	0.24523700360149334
GENIOSPASM 1; GSM1	0.00492611	0.24523700360149334
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.00492611	0.24523700360149334
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.00492611	0.24523700360149334
DESANTO-SHINAWI SYNDROME	0.00492611	0.24523700360149334
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.00492611	0.24523700360149334
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.00492611	0.24523700360149334
CHILDHOOD DISINTEGRATIVE DISORDER	0.00492611	0.24523700360149334
MENTAL RETARDATION, X-LINKED 63	0.00492611	0.24523700360149334
SOTOS SYNDROME 2	0.00492611	0.24523700360149334
PRKAR1B-RELATED NEURODEGENERATIVE DEMENTIA WITH INTERMEDIATE FILAMENTS	0.00492611	0.24523700360149334
WIEDEMANN-STEINER SYNDROME	0.00492611	0.24523700360149334
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.00492611	0.24523700360149334
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25	0.00492611	0.24523700360149334
XQ25 DUPLICATION SYNDROME	0.00492611	0.24523700360149334
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.00492611	0.24523700360149334
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.00492611	0.24523700360149334
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.00492611	0.24523700360149334
COFFIN-SIRIS SYNDROME 6; CSS6	0.00492611	0.24523700360149334
NORRIE DISEASE	0.00492611	0.24523700360149334
XQ25 MICRODUPLICATION SYNDROME	0.00492611	0.24523700360149334
17P11.2 MICRODUPLICATION SYNDROME	0.00492611	0.24523700360149334
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.00492611	0.24523700360149334
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.00492611	0.24523700360149334
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.00492611	0.24523700360149334
LUSCAN-LUMISH SYNDROME; LLS	0.00492611	0.24523700360149334
DYSTONIA-APHONIA SYNDROME	0.00492611	0.24523700360149334
17Q24.2 MICRODELETION SYNDROME	0.00492611	0.24523700360149334
ALAZAMI SYNDROME; ALAZS	0.00492611	0.24523700360149334
16P12.1P12.3 TRIPLICATION SYNDROME	0.00492611	0.24523700360149334
FRAGILE X SYNDROME	0.00492611	0.24523700360149334
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.00492611	0.24523700360149334
MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID	0.00492611	0.24523700360149334
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.00492611	0.24523700360149334
LAMB-SHAFFER SYNDROME	0.00492611	0.24523700360149334
DRAVET SYNDROME	0.00492611	0.24523700360149334
MALAN OVERGROWTH SYNDROME	0.00492611	0.24523700360149334
CLASSIC PHENYLKETONURIA	0.00444444	0.22125798008705064
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.00444444	0.22125798008705064
MITOCHONDRIAL DNA-RELATED PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00444444	0.22125798008705064
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.00444444	0.22125798008705064
LAFORA DISEASE	0.00444444	0.22125798008705064
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.00444444	0.22125798008705064
ACERULOPLASMINEMIA	0.00444444	0.22125798008705064
PROGRESSIVE SUPRANUCLEAR PALSY	0.00444444	0.22125798008705064
SPINOCEREBELLAR ATAXIA 42	0.00444444	0.22125798008705064
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.00444444	0.22125798008705064
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.00444444	0.22125798008705064
CENTRAL NEUROCYTOMA	0.00444444	0.22125798008705064
RETT SYNDROME	0.00444444	0.22125798008705064
NON-24-HOUR SLEEP-WAKE SYNDROME	0.00444444	0.22125798008705064
SPINOCEREBELLAR ATAXIA TYPE 42	0.00444444	0.22125798008705064
SPINOCEREBELLAR ATAXIA TYPE 28	0.00444444	0.22125798008705064
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.00444444	0.22125798008705064
NIEMANN-PICK DISEASE TYPE B	0.00444444	0.22125798008705064
AMYOTROPHIC LATERAL SCLEROSIS AND/OR FRONTOTEMPORAL DEMENTIA 1	0.00444444	0.22125798008705064
PANDAS	0.00444444	0.22125798008705064
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 3; FASPS3	0.00444444	0.22125798008705064
WOLFRAM SYNDROME 2; WFS2	0.00444444	0.22125798008705064
PERRY SYNDROME	0.00444444	0.22125798008705064
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.00444444	0.22125798008705064
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.00444444	0.22125798008705064
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.00444444	0.22125798008705064
HUNTINGTON DISEASE-LIKE 1	0.00444444	0.22125798008705064
SPINOCEREBELLAR ATAXIA TYPE 8	0.00444444	0.22125798008705064
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.00444444	0.22125798008705064
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.00444444	0.22125798008705064
SPINOCEREBELLAR ATAXIA TYPE 10	0.00444444	0.22125798008705064
SPINOCEREBELLAR ATAXIA TYPE 27	0.00444444	0.22125798008705064
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.00444444	0.22125798008705064
MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO	0.00444444	0.22125798008705064
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.00444444	0.22125798008705064
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.00444444	0.22125798008705064
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.00444444	0.22125798008705064
ALZHEIMER DISEASE 9, SUSCEPTIBILITY TO; AD9	0.00444444	0.22125798008705064
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.00444444	0.22125798008705064
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4	0.00444444	0.22125798008705064
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.00444444	0.22125798008705064
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	0.00444444	0.22125798008705064
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.00444444	0.22125798008705064
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.00444444	0.22125798008705064
MAJOR AFFECTIVE DISORDER 1	0.00444444	0.22125798008705064
PARKINSON DISEASE, LATE-ONSET; PD	0.00444444	0.22125798008705064
WILSON DISEASE	0.00444444	0.22125798008705064
SPINOCEREBELLAR ATAXIA 27; SCA27	0.00444444	0.22125798008705064
CEREBROTENDINOUS XANTHOMATOSIS	0.00444444	0.22125798008705064
L1 SYNDROME	0.00444444	0.22125798008705064
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.00444444	0.22125798008705064
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.00444444	0.22125798008705064
ADULT-ONSET DYSTONIA-PARKINSONISM	0.00444444	0.22125798008705064
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.00444444	0.22125798008705064
AGEL AMYLOIDOSIS	0.00444444	0.22125798008705064
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00444444	0.22125798008705064
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.00444444	0.22125798008705064
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.00444444	0.22125798008705064
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.00444444	0.22125798008705064
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.00444444	0.22125798008705064
SPINOCEREBELLAR ATAXIA 14	0.00444444	0.22125798008705064
CHRONIC HICCUP	0.00444444	0.22125798008705064
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.00444444	0.22125798008705064
CADASIL	0.00444444	0.22125798008705064
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 1; FASPS1	0.00444444	0.22125798008705064
HUNTINGTON DISEASE; HD	0.00444444	0.22125798008705064
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.00444444	0.22125798008705064
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.00444444	0.22125798008705064
POSTENCEPHALITIC PARKINSONISM	0.00444444	0.22125798008705064
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.00444444	0.22125798008705064
HURLER SYNDROME	0.00444444	0.22125798008705064
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.00444444	0.22125798008705064
TRIMETHYLAMINURIA	0.00444444	0.22125798008705064
JUVENILE HUNTINGTON DISEASE	0.00444444	0.22125798008705064
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.00444444	0.22125798008705064
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.00444444	0.22125798008705064
GLOMUVENOUS MALFORMATIONS	0.00378788	0.18857239103512194
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.00378788	0.18857239103512194
ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE	0.00378788	0.18857239103512194
COUMARIN RESISTANCE	0.00378788	0.18857239103512194
EPOXIDE HYDROLASE 1, MICROSOMAL	0.00378788	0.18857239103512194
CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2	0.00378788	0.18857239103512194
GLUTATHIONE REDUCTASE	0.00378788	0.18857239103512194
CORONARY ARTERY DISSECTION, SPONTANEOUS	0.00378788	0.18857239103512194
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.00378788	0.18857239103512194
DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF	0.00378788	0.18857239103512194
HEINZ BODY ANEMIAS	0.00378788	0.18857239103512194
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.00378788	0.18857239103512194
LACTOSE INTOLERANCE, ADULT TYPE	0.00378788	0.18857239103512194
FLOOD FACTOR DEFICIENCY	0.00378788	0.18857239103512194
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.00378788	0.18857239103512194
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.00378788	0.18857239103512194
APOLIPOPROTEIN(A)	0.00378788	0.18857239103512194
HYPERPROGLUCAGONEMIA	0.00378788	0.18857239103512194
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00378788	0.18857239103512194
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.00378788	0.18857239103512194
DERMATOLEUKODYSTROPHY	0.00378788	0.18857239103512194
MACULAR DYSTROPHY, CORNEAL, 1	0.00378788	0.18857239103512194
SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	0.00378788	0.18857239103512194
KERATOSIS, FAMILIAL ACTINIC	0.00378788	0.18857239103512194
AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	0.00378788	0.18857239103512194
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.00378788	0.18857239103512194
MACULAR CORNEAL DYSTROPHY	0.00378788	0.18857239103512194
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.00378788	0.18857239103512194
URATE-BINDING GLOBULIN, DECREASE IN	0.00378788	0.18857239103512194
VASCULITIS, LYMPHOCYTIC, NODULAR	0.00378788	0.18857239103512194
ASPARTYLGLUCOSAMINURIA; AGU	0.00378788	0.18857239103512194
VENTRICULAR TACHYCARDIA, FAMILIAL	0.00378788	0.18857239103512194
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL;;ADDISON DISEASE, CONGENITAL	0.00378788	0.18857239103512194
BLOOD GROUP, DUFFY SYSTEM; FY	0.00378788	0.18857239103512194
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.00378788	0.18857239103512194
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.00378788	0.18857239103512194
REFSUM DISEASE	0.00378788	0.18857239103512194
WHITE SPONGE NEVUS OF CANNON	0.00378788	0.18857239103512194
BEETURIA	0.00378788	0.18857239103512194
ZINC, ELEVATED PLASMA	0.00378788	0.18857239103512194
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00378788	0.18857239103512194
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00378788	0.18857239103512194
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.00378788	0.18857239103512194
AREDYLD	0.00378788	0.18857239103512194
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.00378788	0.18857239103512194
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.00378788	0.18857239103512194
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.00378788	0.18857239103512194
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.00378788	0.18857239103512194
POLYCYSTIC OVARY SYNDROME 1	0.00378788	0.18857239103512194
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.00378788	0.18857239103512194
CARDIAC LIPIDOSIS, FAMILIAL	0.00378788	0.18857239103512194
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.00378788	0.18857239103512194
CITRULLINE TRANSPORT DEFECT	0.00378788	0.18857239103512194
CHOROIDAL OSTEOMA, BILATERAL	0.00378788	0.18857239103512194
OVARIAN CANCER	0.00378788	0.18857239103512194
PACMAN DYSPLASIA	0.00378788	0.18857239103512194
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00378788	0.18857239103512194
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00378788	0.18857239103512194
CATECHOL-O-METHYLTRANSFERASE	0.00378788	0.18857239103512194
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.00378788	0.18857239103512194
PARAOXONASE 1	0.00378788	0.18857239103512194
NORMOKALEMIC PERIODIC PARALYSIS	0.00378788	0.18857239103512194
SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	0.00378788	0.18857239103512194
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.00378788	0.18857239103512194
CEREBELLOPARENCHYMAL DISORDER V	0.00378788	0.18857239103512194
CEPHALIN LIPIDOSIS	0.00378788	0.18857239103512194
PREMATURE CENTROMERE DIVISION; PCD	0.00378788	0.18857239103512194
PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF	0.00378788	0.18857239103512194
CARBOXYLESTERASE 1	0.00378788	0.18857239103512194
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00378788	0.18857239103512194
SPINAL ARACHNOIDITIS	0.00378788	0.18857239103512194
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.00378788	0.18857239103512194
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.00378788	0.18857239103512194
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00378788	0.18857239103512194
EHLERS-DANLOS SYNDROME, TYPE VI	0.00378788	0.18857239103512194
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.00378788	0.18857239103512194
ALAND ISLAND EYE DISEASE	0.00378788	0.18857239103512194
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.00378788	0.18857239103512194
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.00378788	0.18857239103512194
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.00378788	0.18857239103512194
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.00378788	0.18857239103512194
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.00378788	0.18857239103512194
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00378788	0.18857239103512194
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00378788	0.18857239103512194
SERTOLI CELL-ONLY SYNDROME	0.00378788	0.18857239103512194
XYLOSIDASE DEFICIENCY	0.00378788	0.18857239103512194
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	0.00378788	0.18857239103512194
ICHTHYOSIS, X-LINKED	0.00378788	0.18857239103512194
ICHTHYOSIS AND MALE HYPOGONADISM	0.00378788	0.18857239103512194
PYRIDOXINE-DEPENDENT EPILEPSY	0.00378788	0.18857239103512194
LUTHERAN SUPPRESSOR, X-LINKED	0.00378788	0.18857239103512194
SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	0.00378788	0.18857239103512194
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.00378788	0.18857239103512194
PREMATURE OVARIAN FAILURE 1	0.00378788	0.18857239103512194
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.00378788	0.18857239103512194
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.00378788	0.18857239103512194
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00378788	0.18857239103512194
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.00378788	0.18857239103512194
PYGMY	0.00378788	0.18857239103512194
REVESZ SYNDROME	0.00378788	0.18857239103512194
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.00378788	0.18857239103512194
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00378788	0.18857239103512194
SODIUM-POTASSIUM-ATPASE ACTIVITY OF RED CELL	0.00378788	0.18857239103512194
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.00378788	0.18857239103512194
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.00378788	0.18857239103512194
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.00378788	0.18857239103512194
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.00378788	0.18857239103512194
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00378788	0.18857239103512194
TESTICULAR GERM CELL TUMOR; TGCT	0.00378788	0.18857239103512194
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00378788	0.18857239103512194
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00378788	0.18857239103512194
PENDRED SYNDROME	0.00378788	0.18857239103512194
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00378788	0.18857239103512194
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00378788	0.18857239103512194
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.00378788	0.18857239103512194
T-SUBSTANCE ANOMALY	0.00378788	0.18857239103512194
PROPERDIN DEFICIENCY, X-LINKED	0.00378788	0.18857239103512194
XM SYSTEM	0.00378788	0.18857239103512194
PSEUDOURIDINURIA AND MENTAL DEFECT	0.00378788	0.18857239103512194
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.00378788	0.18857239103512194
SALLA DISEASE	0.00378788	0.18857239103512194
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.00378788	0.18857239103512194
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00378788	0.18857239103512194
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00378788	0.18857239103512194
LARSEN-LIKE SYNDROME	0.00378788	0.18857239103512194
%608572 BURN-MCKEOWN SYNDROME	0.00378788	0.18857239103512194
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.00378788	0.18857239103512194
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00378788	0.18857239103512194
EMANUEL SYNDROME	0.00378788	0.18857239103512194
DERMATITIS, ATOPIC	0.00378788	0.18857239103512194
CHROMOSOME 10Q26 DELETION SYNDROME	0.00378788	0.18857239103512194
CUTIS LAXA	0.00378788	0.18857239103512194
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00378788	0.18857239103512194
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.00378788	0.18857239103512194
OSTEOGENESIS IMPERFECTA, TYPE V	0.00378788	0.18857239103512194
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00378788	0.18857239103512194
HEREDITARY HYPERFERRITINEMIA-CATARACT SYNDROME	0.00378788	0.18857239103512194
BARTTER SYNDROME	0.00378788	0.18857239103512194
46,XX GONADAL DYSGENESIS	0.00378788	0.18857239103512194
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.00378788	0.18857239103512194
DELETED IN AZOOSPERMIA	0.00378788	0.18857239103512194
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00378788	0.18857239103512194
GONADOBLASTOMA	0.00378788	0.18857239103512194
CUTANEOUS COLLAGENOUS VASCULOPATHY	0.00378788	0.18857239103512194
OSTEOMESOPYKNOSIS	0.00378788	0.18857239103512194
ONCOCYTOMA	0.00378788	0.18857239103512194
MACROCYTOSIS, FAMILIAL	0.00378788	0.18857239103512194
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.00378788	0.18857239103512194
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.00378788	0.18857239103512194
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.00378788	0.18857239103512194
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.00378788	0.18857239103512194
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00378788	0.18857239103512194
CONE-ROD DYSTROPHY 1; CORD1	0.00378788	0.18857239103512194
SCHIZOPHRENIA 4	0.00378788	0.18857239103512194
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.00378788	0.18857239103512194
TRISOMY 18-LIKE SYNDROME	0.00378788	0.18857239103512194
601195 IRON OVERLOAD IN AFRICA;;AFRICAN IRON OVERLOAD;;BANTU SIDEROSIS	0.00378788	0.18857239103512194
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00378788	0.18857239103512194
NEURONAL INTESTINAL DYSPLASIA, TYPE B	0.00378788	0.18857239103512194
MICROCEPHALY-BRAIN DEFECT-SPASTICITY-HYPERNATREMIA SYNDROME	0.00378788	0.18857239103512194
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.00378788	0.18857239103512194
CALVARIAL HYPEROSTOSIS	0.00378788	0.18857239103512194
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00378788	0.18857239103512194
NEONATAL ADRENOLEUKODYSTROPHY	0.00378788	0.18857239103512194
FETAL IODINE DEFICIENCY DISORDER	0.00378788	0.18857239103512194
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00378788	0.18857239103512194
METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	0.00378788	0.18857239103512194
HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	0.00378788	0.18857239103512194
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00378788	0.18857239103512194
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00378788	0.18857239103512194
ETHANOLAMINOSIS	0.00378788	0.18857239103512194
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.00378788	0.18857239103512194
EPILEPSY-TELANGIECTASIA	0.00378788	0.18857239103512194
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.00378788	0.18857239103512194
MYELOPEROXIDASE DEFICIENCY	0.00378788	0.18857239103512194
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.00378788	0.18857239103512194
X-LINKED ADRENOLEUKODYSTROPHY	0.00378788	0.18857239103512194
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.00378788	0.18857239103512194
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.00378788	0.18857239103512194
HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	0.00378788	0.18857239103512194
GAPO SYNDROME; GAPOS	0.00378788	0.18857239103512194
MAGNESIUM, ELEVATED RED CELL	0.00378788	0.18857239103512194
LYMPHOKINE DEFICIENCY	0.00378788	0.18857239103512194
GLUTATHIONURIA	0.00378788	0.18857239103512194
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.00378788	0.18857239103512194
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.00378788	0.18857239103512194
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.00378788	0.18857239103512194
LIPASE DEFICIENCY, COMBINED	0.00378788	0.18857239103512194
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE	0.00378788	0.18857239103512194
HOOFT DISEASE	0.00378788	0.18857239103512194
ACETYLATION, SLOW	0.00378788	0.18857239103512194
BARAITSER-WINTER SYNDROME 1; BRWS1	0.00378788	0.18857239103512194
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.00378788	0.18857239103512194
HYPERLEUCINE-ISOLEUCINEMIA	0.00378788	0.18857239103512194
238800 HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	0.00378788	0.18857239103512194
NEPHROSIALIDOSIS	0.00378788	0.18857239103512194
HYPOASCORBEMIA	0.00378788	0.18857239103512194
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00378788	0.18857239103512194
NEUTROPHIL ACTIN DYSFUNCTION	0.00378788	0.18857239103512194
CONGENITAL ADRENAL HYPERPLASIA	0.00378788	0.18857239103512194
LARON SYNDROME	0.00378788	0.18857239103512194
PITUITARY DWARFISM IV	0.00378788	0.18857239103512194
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.00378788	0.18857239103512194
PLATELET PROSTACYCLIN RECEPTOR DEFECT	0.00378788	0.18857239103512194
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00378788	0.18857239103512194
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00378788	0.18857239103512194
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.00378788	0.18857239103512194
OSTEOGENIC SARCOMA	0.00378788	0.18857239103512194
257960 OCULOTRICHODYSPLASIA; OTD	0.00378788	0.18857239103512194
SPERMATOGENIC FAILURE 1; SPGF1	0.00378788	0.18857239103512194
OCULORENOCEREBELLAR SYNDROME	0.00378788	0.18857239103512194
PROGESTERONE RESISTANCE	0.00378788	0.18857239103512194
INSULIN-RESISTANCE SYNDROME TYPE B	0.0035461	0.17653583425283956
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 1	0.0035461	0.17653583425283956
ISOLATED AGAMMAGLOBULINEMIA	0.0035461	0.17653583425283956
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.0035461	0.17653583425283956
MASTOCYTOSIS	0.0035461	0.17653583425283956
ANISOCORIA	0.0035461	0.17653583425283956
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.0035461	0.17653583425283956
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.0035461	0.17653583425283956
BEHÇET DISEASE	0.0035461	0.17653583425283956
CINCA SYNDROME	0.0035461	0.17653583425283956
KAWASAKI DISEASE	0.0035461	0.17653583425283956
HEMOCHROMATOSIS, TYPE 4; HFE4	0.0035461	0.17653583425283956
TREMOR, HEREDITARY ESSENTIAL, 2; ETM2	0.0035461	0.17653583425283956
PYOGENIC ARTHRITIS-PYODERMA GANGRENOSUM-ACNE SYNDROME	0.0035461	0.17653583425283956
LIPOSARCOMA	0.0035461	0.17653583425283956
GAMMA-HEAVY CHAIN DISEASE	0.0035461	0.17653583425283956
MALIGNANT ATROPHIC PAPULOSIS	0.0035461	0.17653583425283956
PITUICYTOMA	0.0035461	0.17653583425283956
CHRONIC MYELOID LEUKEMIA	0.0035461	0.17653583425283956
MANTLE CELL LYMPHOMA	0.0035461	0.17653583425283956
MAST CELL SARCOMA	0.0035461	0.17653583425283956
HELLP SYNDROME	0.0035461	0.17653583425283956
LIDDLE SYNDROME	0.0035461	0.17653583425283956
HEMOCHROMATOSIS, TYPE 3; HFE3	0.0035461	0.17653583425283956
DUBIN-JOHNSON SYNDROME	0.0035461	0.17653583425283956
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.0035461	0.17653583425283956
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.0035461	0.17653583425283956
PERIPHERAL HYPOTHYROIDISM	0.0035461	0.17653583425283956
RARE HEREDITARY HEMOCHROMATOSIS	0.0035461	0.17653583425283956
SPINAL ARTERIOVENOUS METAMERIC SYNDROME	0.0035461	0.17653583425283956
DERMATOMYOSITIS	0.0035461	0.17653583425283956
MARBURG HEMORRHAGIC FEVER	0.0035461	0.17653583425283956
CONGENITAL ISOLATED ACTH DEFICIENCY	0.0035461	0.17653583425283956
CARNEY TRIAD	0.0035461	0.17653583425283956
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.0035461	0.17653583425283956
COCKAYNE SYNDROME	0.0035461	0.17653583425283956
LASSA FEVER	0.0035461	0.17653583425283956
PARATHYROID CARCINOMA	0.0035461	0.17653583425283956
MACROPHAGIC MYOFASCIITIS	0.0035461	0.17653583425283956
EBSTEIN MALFORMATION	0.0035461	0.17653583425283956
SYSTEMIC CAPILLARY LEAK SYNDROME	0.0035461	0.17653583425283956
PONTIAC FEVER	0.0035461	0.17653583425283956
PRIMARY BILIARY CHOLANGITIS	0.0035461	0.17653583425283956
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.0035461	0.17653583425283956
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 37	0.0035461	0.17653583425283956
TYPHOID	0.0035461	0.17653583425283956
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.0035461	0.17653583425283956
CREATINE PHOSPHOKINASE, ELEVATED SERUM	0.0035461	0.17653583425283956
CRIMEAN-CONGO HEMORRHAGIC FEVER	0.0035461	0.17653583425283956
HENNEKAM-BEEMER SYNDROME	0.0035461	0.17653583425283956
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.0035461	0.17653583425283956
FOLLICULAR LYMPHOMA	0.0035461	0.17653583425283956
LEGIONELLOSIS	0.0035461	0.17653583425283956
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.0035461	0.17653583425283956
COLD AGGLUTININ DISEASE	0.0035461	0.17653583425283956
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.0035461	0.17653583425283956
PRIMARY PARATHYROID HYPERPLASIA	0.0035461	0.17653583425283956
GENETIC HYPERFERRITINEMIA WITHOUT IRON OVERLOAD	0.0035461	0.17653583425283956
UNCLASSIFIED MYELODYSPLASTIC SYNDROME	0.0035461	0.17653583425283956
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.0035461	0.17653583425283956
BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS	0.0035461	0.17653583425283956
CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE III	0.0035461	0.17653583425283956
BOTULISM	0.0035461	0.17653583425283956
ARACHNOIDITIS	0.0035461	0.17653583425283956
MUCOLIPIDOSIS TYPE III	0.0035461	0.17653583425283956
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.0035461	0.17653583425283956
CHOLANGIOCARCINOMA	0.0035461	0.17653583425283956
RIFT VALLEY FEVER	0.0035461	0.17653583425283956
CONGENITAL ANALBUMINEMIA	0.0035461	0.17653583425283956
GENERALIZED GLUCOCORTICOID RESISTANCE SYNDROME	0.0035461	0.17653583425283956
ACUTE PANMYELOSIS WITH MYELOFIBROSIS	0.0035461	0.17653583425283956
SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA	0.0035461	0.17653583425283956
CHRONIC NONBACTERIAL OSTEOMYELITIS/CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.0035461	0.17653583425283956
REYNOLDS SYNDROME	0.0035461	0.17653583425283956
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.0035461	0.17653583425283956
EBOLA HEMORRHAGIC FEVER	0.0035461	0.17653583425283956
BENIGN FAMILIAL INFANTILE EPILEPSY	0.0035461	0.17653583425283956
EOSINOPHILIC FASCIITIS	0.0035461	0.17653583425283956
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.0035461	0.17653583425283956
GAUCHER DISEASE TYPE 3	0.0035461	0.17653583425283956
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B; LGMD2B	0.0035461	0.17653583425283956
GRANULOMATOSIS WITH POLYANGIITIS	0.0035461	0.17653583425283956
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.0035461	0.17653583425283956
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	0.0035461	0.17653583425283956
MYXEDEMA	0.0035461	0.17653583425283956
TETRASOMY 9P	0.0035461	0.17653583425283956
AUTOSOMAL AGAMMAGLOBULINEMIA	0.0035461	0.17653583425283956
WALDENSTRÖM MACROGLOBULINEMIA	0.0035461	0.17653583425283956
SCHNITZLER SYNDROME	0.0035461	0.17653583425283956
PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX	0.0035461	0.17653583425283956
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.0035461	0.17653583425283956
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.0035461	0.17653583425283956
GLIOBLASTOMA	0.0035461	0.17653583425283956
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0035461	0.17653583425283956
PRIMARY MYELOFIBROSIS	0.0035461	0.17653583425283956
ADULT-ONSET STILL DISEASE	0.0035461	0.17653583425283956
VIRAL HEMORRHAGIC FEVER	0.0035461	0.17653583425283956
HEMORRHAGIC FEVER-RENAL SYNDROME	0.0035461	0.17653583425283956
THYMIC EPITHELIAL NEOPLASM	0.0035461	0.17653583425283956
TUBERCULOSIS	0.0035461	0.17653583425283956
ADDISON DISEASE	0.0035461	0.17653583425283956
PEDIATRIC HEPATOCELLULAR CARCINOMA	0.0035461	0.17653583425283956
KAPOSI SARCOMA	0.0035461	0.17653583425283956
KUFOR-RAKEB SYNDROME	0.0035461	0.17653583425283956
GASTROINTESTINAL STROMAL TUMOR	0.0035461	0.17653583425283956
%241150 HYPOKALEMIC ALKALOSIS, FAMILIAL, WITH SPECIFIC RENAL TUBULOPATHY;;HYPOKALEMIA, FAMILIAL;;GULLNER SYNDROME	0.0035461	0.17653583425283956
ACUTE ADRENAL INSUFFICIENCY	0.0035461	0.17653583425283956
CLASSICAL EHLERS-DANLOS SYNDROME	0.0035461	0.17653583425283956
CYCLIC NEUTROPENIA	0.0035461	0.17653583425283956
IGG4-RELATED RETROPERITONEAL FIBROSIS	0.0035461	0.17653583425283956
ATYPICAL JUVENILE PARKINSONISM	0.0035461	0.17653583425283956
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.0035461	0.17653583425283956
NON-FUNCTIONING PARAGANGLIOMA	0.0035461	0.17653583425283956
LEISHMANIASIS	0.0035461	0.17653583425283956
KIKUCHI-FUJIMOTO DISEASE	0.0035461	0.17653583425283956
SYSTEMIC SCLEROSIS	0.0035461	0.17653583425283956
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.0035461	0.17653583425283956
SATOYOSHI SYNDROME	0.0035461	0.17653583425283956
POST-TRAUMATIC PITUITARY DEFICIENCY	0.0035461	0.17653583425283956
ATHYREOSIS	0.0035461	0.17653583425283956
FAMILIAL THYROID DYSHORMONOGENESIS	0.0035461	0.17653583425283956
THYROID HEMIAGENESIS	0.0035461	0.17653583425283956
THYROID HYPOPLASIA	0.0035461	0.17653583425283956
X-LINKED AGAMMAGLOBULINEMIA	0.0035461	0.17653583425283956
POLYCYTHEMIA VERA	0.0035461	0.17653583425283956
RELAPSING FEVER	0.0035461	0.17653583425283956
LYME DISEASE	0.0035461	0.17653583425283956
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.0035461	0.17653583425283956
SEVERE CONGENITAL HYPOCHROMIC ANEMIA WITH RINGED SIDEROBLASTS	0.0035461	0.17653583425283956
PORPHYRIA	0.0035461	0.17653583425283956
SYMPTOMATIC FORM OF HEMOCHROMATOSIS TYPE 1	0.0035461	0.17653583425283956
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.0035461	0.17653583425283956
PANHYPOPITUITARISM	0.0035461	0.17653583425283956
PROLACTINOMA	0.0035461	0.17653583425283956
POSTPOLIOMYELITIS SYNDROME	0.0035461	0.17653583425283956
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.0035461	0.17653583425283956
CRONKHITE-CANADA SYNDROME	0.0035461	0.17653583425283956
MULTIPLE MYELOMA	0.0035461	0.17653583425283956
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.0035461	0.17653583425283956
FUNCTIONING GONADOTROPIC ADENOMA	0.0035461	0.17653583425283956
NON-FUNCTIONING PITUITARY ADENOMA	0.0035461	0.17653583425283956
POEMS SYNDROME	0.0035461	0.17653583425283956
KLATSKIN TUMOR	0.0035461	0.17653583425283956
